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Until recently, healthcare was predominantly based on the biomedical model(1, 2). This model 
focused on illness and treatment from a biomedical perspective, and therefore placed a central role 
on the knowledge of the healthcare professional(3). Healthcare professionals tended to make 
decisions about treatments in the best medical interest of the patient, but made these decisions 
mostly unilaterally and based on their own knowledge, often without consulting the patient, even if 
the patient was mentally competent(2, 4). This resulted in a sometimes asymmetrical relationship 
between the patient and the healthcare professional(5, 6). Nowadays, there is a larger emphasis on 
the individual choice and autonomy of the patient (5). A patient is no longer only considered to be a 
mere collection of biological symptoms and a passive recipient of care, but is approached based on 
the biopsychosocial model of health(7). This biopsychosocial approach entails that an illness exists on 
interacting biological, psychological and social levels, making the illness experience unique for each 
patient(8-10). Many organisations, including the World Health Organization (WHO), endorse this 
patient-centred approach, and recommend to place more emphasis on the needs and preferences of 
the individual patient(11, 12). A more equal relationship between the patient and the healthcare 
professional is encouraged, and shared decision-making, defined as “an approach were clinicians and 
patients make decision together using the best available evidence, and where patients are encouraged 
to consider options and the likely benefits and harms of each, to achieve informed preferences and 
decisions”(13, 14), is viewed as an important component in many decisions made about treatment 
and care(1). In this approach, a major role and responsibility is placed on the patient. The patient is 
expected to be an expert on his or her health and an active user of care. However, this delegated 
proactive role of the patient can place high demands on the patient: The patient has to organise and 
coordinate care in an increasingly fragmented, specialised and complex healthcare system, and has to 
do this alongside the demands of daily life(15, 16). It is not known to what extent patients are willing 
and able to take this active role in their care(17, 18). 
 
Self-management 
In 2011, a group of international health experts proposed a new definition of ‘health’, in which health 
is described as “the ability to adapt and to self-manage in the face of social, physical, and emotional 
challenges” (19). Self-management in this sense can be defined as “the individual’s ability to manage 
the symptoms, treatment, physical and psychosocial consequences and lifestyle changes inherent in 
living with a chronic condition”(20). One cannot not self-manage. If a patient decides not to engage in 
some sort of health behaviour, this can be considered ‘self-management’ as well(21). The term ‘self-
management’ was first used in 1976 by the American psychologist Thomas Creer and colleagues in an 
article about rehabilitation and childhood asthma(21, 22). They based this term on the early writings 
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of the Canadian psychologist Albert Bandura, and used the term self-management to indicate that the 
patient has an active role in his treatment(21). Corbin and Strauss built on this work, and described 
how a patient has to self-manage in three different areas (21, 23, 24): 1) the illness, or ‘medical 
management’, such as taking medication and symptom management; 2) everyday life, or ‘maintaining, 
changing, and creating new meaningful behaviours or life roles’, such as household activities, work 
and relationships; and 3) their ‘biography’. Biography relates to identifying and maintaining an identity 
over a life course. An illness might potentially disrupt the patient’s concept of the self, and the patient 
has to make the illness part of his or her identity, by coming to terms with one’s own mortality and 
creating a new meaning in life(25). Self-management is thus a comprehensive concept, which is 
incorporated in the new proposed definition of health. A study of 2078 Dutch healthcare professionals 
from different professions (physicians, nurses and physiotherapists), patients, policymakers and 
researchers showed that the majority of respondents have positive associations with the new 
definition of health and think it is positive that it refers to self-management(26). However, 42% of the 
respondents are in doubt whether all patients are capable of self-management(18, 26). 
Self-management gained increasing attention in research and practice(20). Studies on self-
management largely focus on patients with chronic illness, such as arthritis, diabetes or asthma(20, 
21). These studies showed that learning patients to effectively self-manage their illness led to a better 
self-reported health, less distress and fatigue, higher energy levels, more illness-related knowledge, 
better symptom management and less experienced limitations in social participation(20). Also, 
healthcare costs dropped(27). Less is known about the self-management of patients with advanced 
illness. Patients with advanced illness might face problems that are unique for this patient population, 
such as a large emotional, social and spiritual impact due to the knowledge that death is nearby (28, 
29), and an uncertain illness trajectory with periods of experiencing multiple symptoms that could 
result in suffering (30, 31). 
 
Advance care planning 
An expression of self-management which may be relevant for patients with advanced illness is 
advance care planning (ACP). ACP can be defined as “enabling individuals to define goals and 
preferences for future medical treatment and care, to discuss these goals and preferences with family 
and health-care providers, and to record and review these preferences if appropriate”(32). It consists 
of three key elements: 1) reflection on wishes and preferences for future medical treatment and care; 
2) discussing these with healthcare professionals and relatives; and 3) recording and, if necessary, 
reviewing these preferences. ACP is relevant for patients with advanced illness, since patients in the 
last phase of life often have to make numerous decisions on treatment and care. 
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The term ACP was first used in the late 1980s and early 1990s(33-36) . Originally, it focused on 
the patient’s completion of written documents, such as advance care directives or do-not-resuscitate 
orders, to be used in case the patient lost mental capacity in order to make decisions for him or 
herself(32). Nowadays, ACP is no longer seen as the mere completion of these documents, but as a 
process of thinking and talking about wishes and preferences at the end of life, with the option of 
drawing these up in an advance care directive(37, 38). ACP empowers patients to formulate their 
preferences about treatment and care, based on their values and beliefs. The process of ACP can both 
be used to extend the decisional capacity of the patient when he or she becomes mentally 
incompetent, but can also serve as a basis for patients who retain their mental competence(34). ACP 
helps patients thinking about and preparing for death (37, 39). 
A systematic review on the effects of ACP on end-of-life care by Brinkman-Stoppelenburg and 
colleagues(34), showed that ACP has a positive impact on end-of-life care and quality of life. Research 
on ACP often focusses on patients with cancer(34). ACP could be very beneficial to other groups as 
well, but some research has shown that other groups of patients, such as those with cardiovascular 
disease, engage in ACP less often than patients with cancer(40-44). However, little research has been 
done on ACP in non-cancer populations(45, 46). 
 
Cancer and cardiovascular disease 
In this PhD thesis, I will focus on two populations: patients with cancer in an advanced stage, and 
patients with cardiovascular disease, in particular those with an implantable cardioverter defibrillator 
(ICD). Cancer and cardiovascular disease are currently the two main causes of death worldwide(47). 
For both patient groups, self-management and ACP might be very important and relevant, due to the 
far-reaching implications of the illness on everyday life and due to the extended illness trajectory(48). 
In the following section, I will briefly describe both patient groups. 
 
Advanced cancer 
Cancer is a common diagnosed illness(47). On January 1st, 2018, more than 600.000 people in the 
Netherlands had some sort of cancer, with the most common types being breast cancer (136.100 
patients), skin cancer (109.500 patients), prostate cancer (83.800 patients) and colon cancer (80.500 
patients)(49). In 2018, 47.000 people died of cancer, which makes it the most common cause of death 
in the Netherlands, accounting for 30% of all deaths(50). The illness trajectory of advanced cancer is 
usually rather predictable, and is characterised by a gradual and stable phase with little deterioration 
in health which can take several years, after which a sudden and rapid decline in health will take place, 
which will eventually end with death (Figure 1)(48). 
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 Advanced cancer is cancer that cannot be cured anymore(51). This does not directly mean 
that the cancer is not treated. Rather, treatments no longer focus on curing the illness, but have a 
palliative approach: slowing down the illness progression and prolonging life, controlling symptoms 
and maintaining quality of life(52). Advanced cancer greatly disrupts the patient’s life, with many 
symptoms in physical, psychological, social and spiritual domains, such as pain, fatigue, lack of energy, 
depression, anxiety, and spiritual distress, which can range from mild to very severe(53-55).  
Self-management is important for patients with advanced cancer to deal with the 
consequences the illness has on daily life(52, 56). However, research on self-management of patients 
with cancer usually focusses on cancer in non-advanced stages. Living with advanced cancer may be 
very different, since the patient is living with the knowledge of having a shorter and uncertain life 
expectancy, an inevitable deterioration in health and often a high symptom burden(29, 31). Also, due 
to new treatments and technology, patients with advanced cancer live longer than before, and as a 
consequence need to deal with uncertainty and the consequences of the illness on a longer term(57, 
58). Patients often spend the largest part of their time at home and not in contact with their healthcare 
professionals, trying to live with the consequences of their illness and treatment. However, this part 
is relatively unknown to clinicians and researchers. Better insight in the self-management of patients 
with advanced cancer and the difficulties they experience will shed more light on the complexity and 
on the necessity and importance of self-management. Also, better insight is important to be able to 
provide the best support for these patients(56). Therefore, I will examine self-management of patients 
with advanced cancer in this thesis. 
 
Cardiovascular disease – the implantable cardioverter defibrillator 
Cardiovascular disease is, after cancer, the second leading cause of death in the Netherlands. In 2018, 
38.000 patients died of the consequences of cardiovascular disease, accounting for 25% of the deaths 
in the Netherlands(50). Chronic cardiovascular disease is characterised by episodes of acute illness, 
from which patients may recover (Figure 1)(48). In these episodes, patients are often hospitalised and 
receive intensive treatment. Patients usually survive numerous episodes of acute illness, although a 
decline in health and functioning is apparent in the long term. Although a patient could die in any of 
these episodes, the eventual time of death is uncertain, which can give the feeling of a sudden and 





A proportion of patients with cardiovascular disease have an ICD implanted. The ICD is a small 
electronic device, developed by the cardiologists dr. Michel Mirowski and dr. Morton Mower in the 
late 1960s (Figure 2) (59, 60). It is implanted under the skin of the chest or abdomen of the patient, 
and has up to three electrodes or ‘leads’ running into the heart(61). It constantly analyses the hearth 
rhythm and intervenes when a ventricular arrhythmia arises, by giving rapid electronic pulses (anti-
tachycardia pacing; ATP), or a strong electrical shock, thereby preventing death(62). The ICD also has 
a pacemaker function. The ICD is implanted for secondary prevention in patients who have 
experienced a cardiac arrest prior to receiving the ICD, or, more often, for primary prevention in 
patients who have a higher risk of a cardiac arrest, but not yet experienced one(63). It is estimated 
that in the Netherlands, 55.000 people have an ICD, and this number is rising(64, 65). In 2018, 6413 
new ICDs were implanted(66). 
 Although the ICD is aimed at prolonging life, patients will eventually die, either due to a 
deterioration of their underlying heart disease, other illnesses such as cancer, or old age(67). For ICD 
patients who are in the last phase of life, the ICD could potentially complicate the dying process, by 
 
Figure 1. Illness trajectories of cancer (first graph) and heart and lung failure (second graph), 
adapted from Murray et al. 2005(48) 
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delivering inappropriate shocks. A landmark study from the USA, performed by Goldstein and 
colleagues in 2004, showed that up to 27% of patients experienced a shock in the last month before 
death, and 8% of patients experienced shocks in the last minutes(68). Another study from Sweden 
from 2014 showed that this percentage was even higher: up to 31% of patients received an ICD shock 
in the last 24 hours of life(69). 
ICD patients in the last phase of life may be faced with the decision whether or not to 
deactivate the shock function of their ICD at some point, to avoid inappropriate shocks. However, this 
is not a conversation easily started or a decision easily made. At the same time, having conversations 
with patients is crucial to make them aware of the implications of having an active ICD at the end of 
life. Multiple guidelines have elaborated on this, and recommend to timely and frequently discuss ICD 
deactivation throughout the illness trajectory(67, 70, 71). It is however unknown to what extend these 
conversations are held, and whether these lead to an increase in deactivation. ACP could potentially 
be helpful for patients with an ICD to think, talk, and record their preferences about ICD deactivation. 
ACP has rarely been studied in cardiology, and specifically in patients with an ICD, while ACP could be 
very relevant for these patients(45). Therefore, in this thesis, I will examine the last phase of life and 
the practice of ACP in a population of patients with an ICD. 
 




Aims and research questions 
The overall aim of this thesis is to provide insight into the self-management behaviours and ACP 
practices of patients living with advanced illness. This thesis includes studies on self-management in 
patients with advanced cancer and studies on ACP in patients with cardiovascular disease, specifically 
those with an ICD. 
 
Part I of this thesis addresses self-management in a population of patients with advanced cancer. The 
aim of this part is to better understand the consequences of having advanced cancer and patients’ 
self-management to deal with these consequences. Further, the aim was to examine healthcare 
professionals’ experiences and attitudes towards patients’ self-management, and their perceived 
roles in self-management support. 
 
The research questions of part I of this thesis are: 
1. How do patients with advanced cancer deal with the consequences of their illness and its 
treatment? 
2. What factors influence self-management of patients with advanced cancer? 
3. What are the experiences and attitudes of healthcare professionals towards self-management 
of patients with advanced cancer, and what self-management support roles can be 
distinguished? 
 
Part II of this thesis focusses on patients with an ICD. The aim of this part is to examine the last phase 
of life of patients with an ICD, and to examine the experiences of patients, relatives, and healthcare 
professionals with ACP conversations about whether or not to deactivate the shock function of the 
ICD. 
 
The research questions of part II of this thesis are: 
4. What is the impact of having an active ICD in the last phase of life? 
5. How and when are decisions about ICD deactivation made, and what factors influence these 
decisions? 
6. What barriers do patients and relatives experience towards ACP conversations about ICD 
deactivation? 





Outline of this thesis 
Part I of this thesis (chapter 2 to 4) aims at describing self-management in a population of patients 
with advanced cancer. Chapter 2 gives an extensive overview of the literature on this topic and covers 
the self-management strategies patients with advanced cancer use on which domains. Chapter 3 
covers a large qualitative study in Dutch patients with advanced cancer, to explore the consequences 
of living with advanced cancer, to explore their self-management, and to examine the factors that 
influence self-management. Chapter 4 covers the experiences of healthcare professionals with self-
management support of patients with advance cancer. 
Part II of this thesis (chapter 5 to 9) aims at describing ACP in a population of patients with an 
ICD. Chapter 5 presents a systematic review on ICD shock incidence and the impact of these shocks at 
the end of life. Chapter 6 covers a retrospective case study on a Dutch population of deceased ICD 
patients, and describes the ICD shock incidence, the occurrence of deactivation conversations and 
deactivation rates. Chapter 7 and chapter 8 describe the experiences of ICD patients and their 
relatives with the last phase of life, their experiences with ACP, and the barriers towards ACP. Chapter 
9 covers a viewpoint which elaborates on the barriers healthcare professionals experience concerning 
ACP in patients with an ICD, and how these could be overcome. The main findings of chapter 2 through 
9 are discussed and reflected on in chapter 10 and are summarised in chapter 11. 
 
Part I of this thesis was financially supported by the Netherlands Organization for Health Research and 
Development (ZonMw, grant number 80-84400-98-076). Part II of this thesis was financially support 
by the Innovational Research Incentives Scheme Vidi of the Netherlands Organisation for Scientific 
Research (NWO, grant number 91717386, dr. Rietjens) and by an EUR Fellowship of the Erasmus 
University Rotterdam (dr. Rietjens). All these funding organisations did not have any involvement in 
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Patients with advanced cancer are increasingly expected to self-manage. Thus far, this topic has 
received little systematic attention. 
Aim 
To summarise studies describing self-management strategies of patients with advanced cancer and 
associated experiences and personal characteristics. Also, to summarise attitudes of relatives and 
healthcare professionals towards patient self-management. 
Design 
A systematic review including non-experimental quantitative and qualitative studies. Data were 
analysed using critical interpretive synthesis. Included studies were appraised on methodological 
quality and quality of reporting. 
Data sources 
MEDLINE, Embase, Cochrane Central, PsycINFO, CINAHL, Web of Science and Google Scholar (until 11 
June 2019). 
Results 
Of 1742 identified articles, 31 moderate-quality articles describing 8 quantitative and 23 qualitative 
studies were included. Patients with advanced cancer used self-management strategies in seven 
domains: medicine and pharmacology, lifestyle, mental health, social support, knowledge and 
information, navigation and coordination and medical decision-making (29 articles). Strategies 
were highly individual, sometimes ambivalent and dependent on social interactions. Older patients 
and patients with more depressive symptoms and lower levels of physical functioning, education and 
self-efficacy might have more difficulties with certain self-management strategies (six articles). 
Healthcare professionals perceived self-management as desirable and achievable if based on 
sufficient skills and knowledge and solid patient–professional partnerships (three articles). 
Conclusion 
Self-management of patients with advanced cancer is highly personal and multifaceted. Strategies 
may be substitutional, additional or even conflicting compared to care provided by healthcare 
professionals. Self-management support can benefit from an individualised approach embedded in 






Learning that one’s cancer has progressed to an advanced and incurable stage is for most patients and 
their relatives an overwhelming experience that often includes shifting from curative treatment to 
focusing on life extension and/ or quality of life. Because patients have to live with the prospect of 
impending death and are increasingly unable to continue their daily activities and fulfil their usual 
social roles, they need to deal with considerable emotional, psychosocial and lifestyle 
consequences(1). They do this in the face of increasing multidimensional symptoms, such as fatigue, 
pain, anxiety and depression(1–4). Although usually, many healthcare providers are involved in 
medical care(5,6), most of the time, patients, together with their relatives, need to manage a huge 
part of their care and lives them- selves. This can be highly complex. 
In recent years, patients have been increasingly stimulated to actively manage their health: 
healthcare policies have shifted towards out-of-hospital delivery of care, partly driven by increasing 
numbers of patients(7), workforce challenges(8) and a tendency to reduce costs(9). Self-management 
has frequently been studied in the context of chronic diseases, such as diabetes. In this context, self- 
management has been defined as ‘the person’s ability to manage the symptoms, treatment, physical 
and psycho-social consequences and lifestyle changes inherent in living with a chronic condition’(10). 
Key to this definition is that self-management involves more than management of problems in the 
medical domain. A growing body of evidence demonstrates that people living with chronic conditions 
might use a wide range of self-management strategies, such as adhering to a special diet and dealing 
with emotions(10–18). 
Because advanced cancer is generally characterised by a shorter prognosis compared to 
chronic diseases, such as diabetes, and increased complexity of healthcare (including rapid medical-
technological developments, such as immunotherapy), self-management domains and strategies 
observed among patients with chronic diseases can- not self-evidently be extrapolated to patients 
with advanced cancer. Yet, self-management of patients with advanced cancer has received 
surprisingly little systematic attention. Several studies have assessed the topic, but among these 
studies, there is a lack of conceptual clarity (e.g. inconsistent use of terms like self-management, self- 
care and self-help; either a broad focus or a focus on certain domains, such as symptom self-
management) and a large degree of heterogeneity regarding study designs and patient populations 
(e.g. all cancer types vs specific cancer types). Previous reviews have shown that patients with 
advanced cancer engage in multiple different self- management behaviours, including psychosocial 
and emotional strategies, to manage the end of life, such as preparing for death(19,20). However, one 
systematic review was published in 2009(20), whereas especially in the past decade, healthcare 
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policies have increasingly steered towards out-of-hospital care and patient self-management, 
presumably affecting self-management experiences. The other review concerns a scoping review that 
predominantly focuses on self-management support interventions and lacks quality appraisal of the 
included studies(19) In addition, both reviews only assess patient perspectives, while it is also relevant 
to include perspectives of relatives and healthcare professionals(21–25). Comprehensive insight in 
self-management of this vulnerable patient population is needed to develop healthcare policies and 
self-management support programmes that are tailored to the needs and abilities of patients and 
their relatives, while also fitting in the healthcare system. Hence, this integrated systematic review of 
empirical studies aimed to obtain this insight by thoroughly analysing the non-experimental evidence 
currently available. For the population of patients with advanced cancer, we therefore examined the 
following: 
 
1. The concept of self-management and its domains; 
2. Patients’ self-management strategies and corresponding experiences; 
3. Patient characteristics that might be associated with the use of self-management strategies; 





Following the principles of a mixed research synthesis(26), we conducted a systematic review(27) of 
published non- experimental quantitative and qualitative research. We used the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines for reporting and presentation 
of the flow of information through the different phases of the review(28). 
 
Data collection 
With help of biomedical information specialists (G.d.J. and W.B.), systematic electronic searches were 
per- formed in MEDLINE (Ovid), Embase, Cochrane Central, PsycINFO (Ovid), CINAHL (EBSCO), Web of 
Science and Google Scholar from inception until 11 June 2019. Supplementary Table 1 lists the search 
terms. Search components consisted of Medical Subject Headings (MeSH terms) or equivalent and 
free text words related to (1) self-management (identified using MeSH trees and search strings of 
previous research) and (2) advanced cancer. No automatic restrictions were placed on study type and 





Articles were included when they met the inclusion criteria (see Box 1). To determine eligibility of 
articles that purported to be on self-management (or a related search term), we adapted Barlow’s 
self-management definition to the context of advanced cancer(10). The advanced cancer criterion was 
considered met when articles specifically addressed a population of patients with cancer that was 
‘unlikely to be cured’.29 Healthcare professionals may also use the terms ‘secondary’, ‘metastatic’, 
‘terminal’ or ‘progressive’ cancer to describe it. Studies were only included if they reported results 
specifically for this patient group (i.e. studies addressing a mixed population with various cancer stages 
were excluded if they did not stratify results according to cancer stage). We selected articles with non- 
experimental quantitative, qualitative and mixed-method study designs(26). 
Two reviewers (K.d.N. and S.I.v.D.) independently used a stepwise procedure to identify 
relevant articles. In case of disagreement, consensus was reached through discussion with a third 
reviewer (J.A.C.R.). Study selection was carried out with the online software Covidence(30). Articles 
were first screened based on title and abstract. Subsequently, remaining articles were screened based 
on full text. Articles of references selected for full text evaluation were downloaded, or, if not 
electronically available, requested from the first author. If full text articles were excluded, the first of 
the hierarchical inclusion criteria not satisfied (see Box 1) was considered the main reason for 
exclusion. 
Box 1. Inclusion criteria for study selection. 
1. Articles concerning self-management (i.e. ‘the strategies used by persons to manage the 
symptoms, treatment, physical and psychosocial consequences and lifestyle changes inherent 
in living with advanced cancer’)(10). 
2. Articles concerning patients with advanced cancer (i.e. ‘cancer that is unlikely to be cured’)(29). 
3. Articles concerning perspectives of patients with advanced cancer, their relatives (not 
necessarily restricted to family members, but could also include significant others, for example, 
close friends) and/or healthcare professionals. 
4. Articles concerning empirical research with a non- experimental quantitative, qualitative or 
mixed-methods study design and a sample size of ⩾1 (i.e. no case studies, case reports, reviews 
and intervention studies)(26). 
5. Articles published in the English or Dutch language in peer-reviewed scientific journals (i.e. no 
conference proceedings, abstracts and posters). 
6. Articles concerning adults (⩾18 years) only. 
 
Quality appraisal 
Two reviewers (K.d.N. and R.S.) independently appraised the quality of included studies. 
Methodological quality of quantitative studies was assessed using a modified version of the guidelines 
of Cochrane Netherlands(31,32). This form consists of the following seven items: (1) research 
hypothesis, (2) study population, (3) selection bias, (4)exposure, (5) outcome, (6) confounding and (7) 
general opinion. Each criterion was assigned a score of 1 when it was sufficiently met, a score of 0 
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when it was insufficiently met or a question mark when it could not be rated due to lacking 
information. For each of the studies, a total score was calculated (ranging from 0 to 7). The quality of 
reporting of the qualitative studies was assessed with the consolidated criteria for reporting 
qualitative research (COREQ) checklist, which is recommended by Cochrane Netherlands(33). The 
COREQ checklist also includes aspects of methodological quality and is applicable to various types of 
qualitative research(33,34). It consists of 32 items that evaluate three domains, that is, (1) research 
team and reflexivity, (2) study design and (3) analysis and findings. Each criterion was assigned a score 
of 1.0 when it was properly described, a score of 0.5 when it was partially described or a score of 0.0 
when it was not or unclearly described. For each of the studies, a total score was calculated (ranging 
from 0.0 to 32.0). Disagreements were discussed and resolved. 
 
Data extraction and data analyses 
To systematically extract data from included articles, we developed a data extraction form. This form 
included items on general study characteristics and characteristics of the study population. It also 
included open items about the definition of self-management and the self-management strategies 
addressed. We also extracted information regarding patients’ experiences and characteristics 
associated with these self-management strategies. In addition, we extracted information concerning 
the attitudes of relatives and healthcare professionals towards patient self- management. The 
extraction form was completed by two reviewers (K.d.N. and S.I.v.D.); disagreements were solved by 
discussion. 
Data were analysed using critical interpretive synthesis(35). Departing from the framework of 
self-management support components developed by Barlow and colleagues in the context of chronic 
diseases(10), we categorised self-management strategies into domains. Subsequently, we integrated 
data on self-management strategies with data on corresponding experiences, and compared these 
findings within and across self-management domains. In addition, we interpreted findings in light of 
self-management definitions provided by the included studies and com- pared them with findings 





The database search yielded 2935 articles (see PRISMA flowchart in Figure 1). After removal of 
duplicates, 1742 articles were screened based on title and abstract. The remaining 187 articles were 
screened based on full text. Finally, 31 articles about 31 unique studies were included for analysis. 
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Eight of these articles had a quantitative study design and 23 of them had a qualitative study design 
(see Table 1). 
 
 
Figure 1. Process of study selection (PRISMA flowchart). 
 
Quality of included studies 
For non-experimental quantitative studies, the mean total methodological quality score was 5 out of 
7 (range: 4–7; see Table 1). The studies had good ratings on the criteria for ‘Research hypothesis’, 
‘Study population’ and ‘Outcome’, but nearly all of them scored poorly on the criteria for ‘Selection 
bias’ and ‘Confounding’. For qualitative studies, the mean total score for quality of reporting was 
19.0 out of 32.0 (range: 12.5–25.0). Almost all qualitative studies had poor ratings on the first domain, 
‘Research team and reflexivity’. Generally, studies with the highest scores on the first domain also 
provided sufficient information on the domains ‘Study design’ and ‘Analysis and findings’, thus 





Study populations of 28 studies consisted of patients (see Table 1), one study was conducted among 
healthcare professionals only, and two studies contained both groups. None of the studies assessed 
the perspective of relatives. All but seven articles described assessment of self-management of 
patients residing primarily at home(36–42). Except for five studies that were performed in Brazil, 
China, Thailand and Turkey, respectively(36–38,41,42), studies were conducted in high-income 
countries, such as Australia (seven studies), Canada (one study), the United Kingdom (eight studies), 
the United States (five studies) and Scandinavia (five studies). Eighteen studies included various cancer 
diagnosis groups; the other studies specifically focused on lung cancer(38), breast cancer(36,43–47), 
prostate cancer(48), hepatocellular cancer(49) or myeloma(43). Some studies focussed on assessing 
specific self-management strategies, such as medication management(50), or the use of 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The concept of self-management and its domains in patients with advanced cancer 
Self-management definitions. Twenty-one of the 31 included articles did not explicitly define self-
management or any of the related terms. Three of the included articles provided a definition of ‘self-
management’(47,52,53). Three other articles defined ‘self-care’(43,54,55). These definitions are 
described in Box 2. One of the definitions relates self- management to self-care, describing self-
management as ‘maintaining ones usual practices of self-care’(55). While some definitions 
conceptualise self-management as behaviours (or strategies, actions, activities, practices)(43,53–55), 
others also include patients’ self-management skills, such as action-planning and using 
resources(47,52). Most definitions focus predominantly on the patient, with one of them explicitly 
emphasising the aim of self-mastering problems rather than relinquishing these to others. Yet, two 
definitions assign a role for relatives and healthcare professionals as well, describing self-management 
as a participatory process that may even be undertaken to serve (well-being of) others(54). Finally, 
the self-management definitions cover various domains of health and functioning and include 
different self-management outcomes, for example, enhanced quality of life(43,54), maintenance of 
physical and mental health and/or daily functioning(43,54), reduced symptom burden(53) and 
increased coping(53). 
Self-management domains. Self-management strategies used by patients in the 29 non-
experimental quantitative and qualitative studies could be categorised into seven overarching 
domains: medicine and pharmacology, lifestyle, psychology/mental health, social support, knowledge 
and information, navigation and coordination and medical decision-making (see Table 2). Five studies 
pro- vided information about one self-management domain(36,40,51,54,55), five studies reported on 
two self-management domains(44,56–59) and the remaining 19 studies covered three or more self-
management domains. 
 
Box 2. Definitions of self-management or related terms in the included articles. 
‘Self-management’ (three articles): 
• ‘Self-management has been defined as any behaviour which an individual engages in 
specifically to try and relieve, minimise or prevent pain or more broadly to cope with their 
illness’(53). 
• ‘Self-management involves daily behaviours that individuals perform to handle a health 
condition, it includes the skills of problem solving, goal setting, decision making, using 
resources, forming patient- provider partnerships, action planning, and self- tailoring’.47 
• ‘Self-management has been described as a participatory process where patients and clinicians 
develop strategies together to equip patients with the skills and knowledge to manage the 
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impact of the condition, monitor their disease and make effective use of support services 
outside of the clinical setting’(52). 
‘Self-care’ (three articles): 
• ‘Self care includes the actions individuals and carers take for themselves, their children and their 
families to stay fit and maintain good physical and mental health; meet social and psychological 
needs; prevent illness or accidents; care for minor ailments and long-term conditions; and 
maintain health and well-being after an acute illness or discharge from hospital’(54). 
• ‘Self-care can be used as an umbrella term to refer to all activities of self-management. [. . .]. It 
is defined as “maintaining ones usual practices of self-care – those things that are important 
and unique to oneself in maintaining ones sense of self. . . being given the means to master or 
deal with problems, rather than relinquish them to others”(55). 
• ‘Self-care involves the voluntary use of activities to promote one’s own well-being. Self-care has 
been defined as the range of voluntary activities that an individual uses to maintain life, health 
and well-being’(43). 
 
Self-management strategies and corresponding experiences of patients with advanced cancer 
Non-experimental quantitative results concerning self- management strategies and corresponding 
experiences of patients with advanced cancer are displayed in Table 3. The results of the qualitative 
studies are presented in Supplementary Table 2. 
Medicine and pharmacology. Medical and pharmacological strategies varied from self-
monitoring(49) and self-administering medications and following prescribed treatment 
regimens(37,47,58,60) to adjusting or discontinuing treatment schedules and taking extra doses of 
additional (pain) medications(39,41,42,47,50,52,61–63). Patients used self- monitoring to better 
understand and describe their disease(49). Reasons for not taking medications as prescribed included 
a desire to alleviate suffering(62), attempts to find the optimal balance between beneficial and 
adverse (side) effects(39,50,63), fears of tolerance and addiction(63), non-pharmacological 
alternatives to manage pain(63), preferring ‘grip on the pain’ over ‘becoming pain free’(61), sedative 
side effects that were experienced to be a ‘threat to usual self’(61) and uncertainty about treatment 
efficacy(49). 
 
Table 2. Self-management domains and self-management strategies used by patients with 
advanced cancer (29 studies) 
Self-management domains 
Studies addressing the respective domain: (N) 
Self-management strategies 
Medicine and pharmacology 
(N=14)37,39,41,42,47,49-50,52,58,60,61-63,67 
• Monitoring symptoms, bodily changes, 
treatment effects, and/ or disease risks 
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  • Self-administering medication 
• Adhering to prescribed treatment schedules 
• Adjusting or discontinuing treatment 
schedules (e.g. taking extra drug doses during 
breakthrough pain, replacing conventional 
treatment with alternative therapies, omitting 
use of medications) 
Lifestyle 
(N=26)36,37,40-48,51, 52, 54-63, 65 - 67  
• Adjusting nutrition and diet 
• Adjusting exercise (e.g. exercising more, 
balancing rest and physical activity) 
• Practising complementary and alternative 
medicine (e.g. taking medicinal herbs, 
practising meditation, Reiki, or homeopathy) 
• Practising religion  
• Using relaxation 
• Performing leisure activities (e.g. doing 
sports or creative activities) 
• Maintaining daily routine by adjusting 
activities (e.g. by taking breaks/ naps during 
the day, dividing activities into smaller parts, 
using assistive devices) 
• Not making any lifestyle changes 
Psychology/ Mental health 
(N=9)42, 43,45,46,48,55,60-62 
• Keeping a diary 
• Using mindful self-help strategies (e.g. 
practising assertive self-talk, focusing on 
feelings and thought of control, acceptance, 
and/ or positivity, readjusting purpose, 
expectations and meaning, channelling 
thoughts of own death towards future well-
being of loved ones) 
• Doing meaningful (charity) activities (e.g. 
volunteering, promoting cancer awareness) 
Social support 
(N=22)37,39, 41, 43-48, 50,52,55-57,59-63,65-67  
• Seeking support from relatives and friends 
• Seeking support from healthcare 
professionals 
• Seeking support from other cancer patients; 
engaging in (online) support groups 
• Providing and/ or arranging social support to 
friends and relatives 
• Limiting social interactions to certain people 
or moments (e.g. selective communication, 
social isolation) 
Knowledge and information 
(N=12)39,42,45,47-50,52,60,61,65,67  
• Seeking information about disease and/ or 
treatments 
• Seeking information about self-care 
• Avoiding or neglecting information 
Navigation and coordination 
(N=9)39,42,47,48,50,55,60,62,63 
• Coordinating medical services (e.g. obtaining 
and exchanging health-related documents) 
38 
 
• Delegating aspects of care (e.g. obtaining 
medications, deciding on pain treatment 
approach) to others 
• Coordinating and staying in charge of 
information dissemination to relatives 
• Making financial and practical plans (e.g. 




• Making informed decisions about treatment 
• Engaging in advance care planning 
• Short-term goal-setting 
N: Number 
 
Lifestyle. Within the lifestyle domain, we identified different self-management strategies. 
Three non-experimental quantitative studies showed that 24%–56% of the patients used physical 
exercise to manage symptoms, for instance, fatigue(37, 43,56). Two quantitative studies(37,57) and 
three qualitative studies(46,52,54) showed that many patients changed their diet (i.e. 70%–82% 
adopted a balanced diet). The two quantitative studies also indicated that 92% and 89%, respectively, 
used relaxation to relieve cancer symptoms(37,57). In addition, six quantitative studies showed that 
26%–72% of the patients used at least one complementary and alternative medicine modality 
(classified according to the criteria provided by the National Centre for Complementary and 
Alternative Medicine)(64), such as acupuncture or homoeopathy(36,37,43,56–58). Both quantitative 
and qualitative studies provided evidence that patients experienced benefits from using 
complementary and alternative therapies, such as an improved quality of life(40,51,55,65). Generally, 
health behaviours were adopted or changed in order to prolong life(40,58), boost strength, energy 
and immunity(52,58), improve quality of life(40,51,62), increase feelings of control and 
independence(40,54) and please relatives(40,54). Some patients decided to spend more time on their 
hobbies or engaged in new hobbies to distract them from disease-related symptoms and 
concerns(41,42,48,61–63), maintain physical ability48 or get a sense of enrichment(48,59). At the 
same time, patients indicated to strive for normality and maintenance of usual daily activities: 10 
qualitative studies(45–48,55,59–62,66) and 1 quantitative study(67) showed that this was of great 
importance to most of them among others because it made them feel functional and helped them to 
maintain role, self and independence. For some patients, continuing life as it used to be was so 
important that they deliberately chose not to make any major lifestyle changes at all(45). Other 
patients maintained their daily routine using assistive devices, adjusting activities, dividing tasks into 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Psychology/mental health. Several patients managed their psychological well-being by 
keeping a diary(43) and participating in meaningful charity activities, such as volunteering and 
promoting cancer awareness(46,48). Furthermore, eight qualitative studies showed that patients used 
assertive self-talk or tried to control or accept their situation, readjust purpose, expectations and 
meaning in life, think of their family’s future well-being rather than of their own death and focus on 
positive thoughts (e.g. good memories) and feelings(42,45,46,48,55,60–62). This often enhanced 
coping with the disease, but could also lead to psychological turmoil when motives were 
incompatible(48). 
Social support. Four quantitative(37,43,56,57) and 15 qualitative studies(39,45–
48,50,52,55,59–63,65,66) indicated that many patients sought support from relatives and friends 
(28%– 94% in the quantitative studies). This was mentioned as an effective strategy by 61% and 100% 
of the patients in two quantitative studies on pain management and general symptom management, 
respectively(37,57). Besides seeking social support, providing or arranging social sup- port for relatives 
was also mentioned as a self-management strategy(45–48,62). Patients considered maintaining or 
intensifying relationships with relatives important, because it gave them emotional 
strength(45,57,60,65), provided distraction from their cancer symptoms(62), made them feel 
important and helpful to others(62), protected their identities and usual social roles(48) and enabled 
them to rely on relatives in case their condition would worsen(39). In several qualitative studies, 
however, patients also mentioned that they found it difficult to accept or ask for support from 
relatives and friends, because they did not want to be a burden(55,59–63,65). Some of them only 
asked for help when they could no longer perform their usual activities(50,60,61,63,66) or restricted 
their social contacts to close relatives or moments when they felt good(57,66). Some patients 
mentioned selective communication of their thoughts and emotions or self-isolation as strategies to 
protect themselves and their loved ones from mental and emotional distress(48,52,57,63). A 
quantitative study among women with metastatic breast cancer demonstrated participation in cancer 
support groups (45%), Internet chat groups (8%) and other cancer support programmes (18%)(43). 
Compared to support from relatives and friends, support from fellow patients was sometimes 
perceived to be more effective(55,59,65). Some patients experienced professional support as positive 
when the severity of their pain increased(41), others reported that this depended on the person 
providing it(55,60,62,65). According to other patients, healthcare professionals listened insufficiently 
or paid too little attention to their emotional needs(50,61,65). 
Knowledge and information. Several patients searched for more information about their 
disease, care and treatment(37,39,42,47–49,52,61,65,67). Most of them perceived this as an effective 
strategy to manage symptoms and other disease consequences, as it empowered them to optimise 
44 
 
both their physical and psychological well-being(48,52). Also, lack of understanding of, for example, 
the meaning of palliative care or cancer symptoms could lead to confusion and concerns and, 
subsequently, hamper effective self-management(47,60). However, when obtaining useful 
information was complicated, this could also become a burden(47). Some patients preferred not to 
think, talk or read about cancer over obtaining knowledge and information, as this made them feel 
able to exert control over their disease experiences and protected them from sad feelings(45). 
Navigation and coordination. Three studies described how patients prepared for their death 
by making financial and practical plans (e.g. planning funeral, sorting out affairs)(48,55,62). This was 
considered beneficial, because it enhanced patients’ feelings of control over their death and the future 
well-being of their families, thus also protecting their own identities and family roles(48). In another 
study, patients with advanced breast cancer coordinated medical services between different 
healthcare providers, for example, by collecting and exchanging health-related documents(47). 
Patients also coordinated their care by delegating some of its aspects (e.g. responsibility for making 
and attending medical appointments, decisions on pain treatment approach) to relatives and 
friends(47,50,63), and by delegating or staying in charge of information dissemination from healthcare 
professionals to relatives or vice versa(39,63). A study among older patients who received outpatient 
cancer treatment and lived alone in rural areas showed that these patients perceived limited control 
over practical arrangements (e.g. arranging treatment schedules and public transport back home) and 
experienced navigating through the healthcare system (e.g. ordering tests, making appointments) as 
very energy-consuming(60). 
Medical decision-making. Several patients participated in advance care planning or made 
together with their health-care professionals shared decisions regarding future medical care and 
treatments(47). Others used short-term goal setting as a strategy to reach long-term 
goals(39,48,65,66). Over time, several patients shifted their focus on quality of life, and for this reason, 
some of them considered foregoing treatment(49). 
 
Personal characteristics associated with the use of self-management strategies among patients with 
advanced cancer 
Two studies explored the cross-sectional association between age and self-management strategies 
(see Table 3). Older and younger patients did not differ in pain management strategies(56), but 
younger patients were shown to be more likely than older patients to practise yoga/ meditation and 
to participate in other cancer patient support activities (e.g. cancer retreats)(43). Patients with higher 
levels of physical functioning were more likely to practise physical exercise, while patients with lower 
levels of physical functioning were more likely to keep a diary. Use of complementary and alternative 
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medicine seemed to be more prevalent among patients with higher income levels, larger household 
sizes, no religious affiliation and less need for control over treatment decisions(58). Higher education 
and self-efficacy levels and lower depressive symptom levels were positively associated with 
perceived effectiveness of self-management behaviours(57). Resigned acceptance and negative mood 
were associated with more difficulty(38). Furthermore, patients with lower self-efficacy and more 
anxiety and/or depressive symptoms reported more self-management concerns(67). 
 
Healthcare professionals’ attitudes towards self-management of patients with advanced cancer 
Table 4 summarises the three articles about attitudes of healthcare professionals towards self-
management of patients with advanced cancer. In one study, primary healthcare professionals 
concurred with patients in their view that it is important to view a patient holistically, that is, as an 
entire person rather than an illness, in terms of both self-management and care and treatment by 
others(55). Another study showed that healthcare professionals working in a specialist palliative care 
service perceived patient self-management as both desirable and achievable, but only if undertaken 
in partnership with them(53). Self-management could also be perceived as problematic, for example, 
when patients acted on limited knowledge(53). Some clinical nurse specialists were worried about 
supporting non-pharmacological methods because of the ‘medical model’ of training they had 
received. Nurses suggested more self-management education for patients and their relatives, for 
example, by means of a smart phone app and a webpage that stimulated active participation in 
obtaining information and medical decision-making(53). Community-based palliative care nurses also 
indicated that patients required their instruction and information to adequately educate their 
relatives regarding medication management(39). Communication between patients and healthcare 
professionals was perceived as vital in medication self-management(39). 
 
Table 4. Non-experimental qualitative study results on healthcare professionals’ attitudes towards 
self-management of patients with advanced cancer (three studies). 
First author 
Healthcare professionals (N) 
Attitudes towards patients self-management 
Campling et al.39 
Community-based palliative care 
professionals (N = 19): clinical nurse 
specialist (n = 13), consultant (n = 1), 
inpatient unit nurse (n = 2), 
lecturer/practitioner (n = 1), lead 
nurse/commissioner (n = 1) 
• With regard to patients who adopted an advocacy role 
in medication management, nurses emphasised the 
importance of getting the right drug, via the right route. 
• Nurses found that the educator role, in which patients 
educate their relatives regarding their medication 
management, required their professional instruction and 
information. They indicated the need to refine knowledge 




• Nurses perceived the communicator role, in which 
patients communicate relevant information to healthcare 
professionals, as vital in medication self-management 
Hughes et al.53 
Professionals working in specialist 
palliative care centres (N = 17): 
community clinical nurse specialist (n = 
6), complementary therapist (n = 3), 
hospice nurse (n = 5), hospice social 
worker (n = 1), hospice spiritual care 
coordinator (n = 1), palliative care 
consultant physician (n = 1) 
• Desirable: 
- If patients act autonomously but in partnership 
with healthcare professionals and base decisions 
on information, dialogue and reflections on prior 
experiences. 
- Because it is unrealistic for professionals to 
provide comprehensive and complete solutions 
to patients’ pain problems and enables patients 
to exert control over what is happening to them. 
• Achievable: 
- If patients take responsibility and are motivated 
to try to self-manage their pain. 
- If nurses provide education for patients and 
relatives and introduce self-management options 
early in the disease trajectory (when patients are 
still well enough to learn about self-management 
and act upon this knowledge). 
- Nurses suggested more self-management 
education for patients and relatives, provided in a 
range of formats and introduced early in the 
disease trajectory. Hospice nurses suggested the 
use of a smartphone app and a webpage to 
provide additional information and support 
decision-making among patients and relatives. 
- Non-pharmacological methods of pain relief were 
viewed as active and productive means of self-
management; religious and spiritual practices 
were considered relevant strategies as well 
• Problematic: 
- If patients act on limited knowledge, exercise 
complete autonomy and reject professional 
advice, adopt strategies not supported by the 
medical model of professionals training or fully 
delegate control and responsibility to healthcare 
professionals. 
- If healthcare professionals take away too much 
control and responsibility (resulting in lack of 
understanding among patients and relatives). 
- Clinical nurse specialists were hesitant to support 
non-pharmacological self-management 
strategies because of the ‘medical model’ of 
training they had received. 
Johnston et al.55 
Key professionals referred by patients 
with advanced cancer (N = 20): clinical 
nurse specialist (n = 9), nurse (hospice 
day care) (n = 3), oncologist (n = 1), 
general practitioner (n = 5), clinical 
• Healthcare professionals found it important to view 
patients  from a holistic rather than an illness perspective 
in terms of both self-management and care and 
treatment by others. 
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nurse specialist/hospice doctor (n = 1), 






This review summarised results from 31 non-experimental quantitative and qualitative studies that 
examined self- management of patients with advanced cancer. The vast majority of these studies were 
of acceptable quality and examined self-management from the perspective of patients. Most studies 
included mixed sex and diagnosis groups and had been conducted in Western high-income countries. 
Overall, the reviewed literature clearly shows that self-management of patients with advanced cancer 
covers numerous domains: medicine and pharmacology (e.g. self-administering pain medications), 
lifestyle (e.g. practising complementary and alternative medicine, taking breaks when doing daily 
chores), psychology (e.g. keeping a diary), social support (e.g. engaging in support groups), knowledge 
and information (e.g. seeking treatment information), navigation and coordination (e.g. making 
financial plans) and medical decision-making (e.g. participating in advance care planning). Within each 
of these domains, patients might use multiple strategies that are highly individual, sometimes 
ambivalent and generally aimed at optimising their own well-being and/or (future) well-being of loved 
ones. Healthcare professionals perceive self-management as both desirable and achievable if based 
on sufficient skills, knowledge, information and solid patient–professional partnerships. 
That strategies used by patients with advanced cancer vary widely and sometimes even 
comprise contradictory behaviours is well illustrated by our data on lifestyle self-management 
strategies, which was the domain most often addressed by the included studies. On the one hand, 
patients frequently mentioned that the diagnosis of advanced cancer had caused them to change 
lifestyle habits and start complementary and alternative medicine or new hobbies. On the other hand, 
however, many of them also indicated that they preferred to maintain their usual daily routines as 
much as possible. In the social support domain, self-management strategies also varied strongly, from 
seeking and providing social support to limiting and even avoiding social support. Although most 
patients experienced social support as essential, for some of them, seeking and accepting it was 
hampered by fears of becoming a burden to loved ones and losing their established roles and identity. 
A large diversity of strategies and experiences with these strategies was observed in the other self-
management domains as well. Medical and pharmacological strategies ranged from adhering to 
prescribed treatment to adjusting and discontinuing treatment. Whereas some patients actively 
gathered information about treatment and disease, others avoided obtaining more knowledge, 
because it was too energy-consuming or made them feel sad. More generally, ambiguity and 
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inconsistency in self-management strategies often seemed to reflect a conflict between two seemingly 
opposing attitudes: appreciating life in the present versus planning for the future; readjusting purpose 
and expectations versus maintaining normality and a sense of established identity; and taking control 
versus letting things happen. 
By including a larger number of studies as well as more recent studies, and by focussing more 
specifically on patients’ self-management strategies and healthcare professionals’ attitudes, our 
systematic review provides novel insights compared to the two prior review studies on self- 
management in advanced cancer care(19,20). The scoping review of Budhwani and colleagues merely 
distinguished between physical and psychosocial domains(19), while our review also describes 
domains of lifestyle, knowledge and information, navigation and coordination and medical decision-
making. Furthermore, we provide a more detailed overview of the full range of self-management 
strategies and experiences in these domains, thereby also revealing divergence and ambivalence 
between these strategies and experiences. Only a few studies explicitly defined self-management (or 
self-care). Although these definitions were not univocal regarding the nature of self-management, our 
review’s findings on the divergence of strategies and experiences suggest that the question should 
not be whether or not, but how someone engages in self-management. This corroborates the 
previously proposed idea that ‘one cannot not self-manage’(15) and argues against a normative 
approach to self-management (support). It also implies that self-management, although affected by 
personal and contextual factors, is not restricted to particular settings or disease stages. It may thus 
be facilitated anywhere and anytime (until the very end), if tailored to individual circumstances, 
abilities and preferences. 
The seven domains we distinguished partly overlap with those observed within chronic 
disease populations, the field on which studies about disease self-management have thus far 
predominantly focused. Many of the models proposed to describe and enhance chronic disease self-
management also include domains of social support, information, navigation and decision-
making(10,11,17,18). Remarkable, however, is that the self-management strategies and experiences 
we identified among patients with advanced cancer are generally more divergent and ambivalent than 
those described for patients with chronic, generally less advanced diseases. For example, while we 
found that avoiding or ignoring (medical) information may be a self-management strategy among 
patients with advanced cancer, reviews about self-management among patients with chronic diseases 
merely report on the opposite, that is, seeking and obtaining information(10,68–71). Possibly, the 
prospect of imminent deterioration and, ultimately, death adds to the complexity of self-
management. After all, these prospects can drastically change the way someone relates to space, 
place, time, self and others. These changes, in turn, interact and consequently affect self-
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management, thus complicating its dynamics and increasing its susceptibility to different, potentially 
competing values, priorities and interests. This interpretation is supported by recent chronic disease 
studies showing that self-management is perceived to be more challenging during periods of 
transition, disease progression or acute events (e.g. exacerbations of chronic obstructive pulmonary 
disease)(16,72,73). It also resonates with findings from several advanced disease studies(22,74–78). 
Two recent systematic reviews indicated that patients with advanced diseases were ambivalent 
towards discussing mortality and advance care planning(77,78). Furthermore, a recent literature 
review on life values of elderly people with advanced cancer showed that these patients often 
fluctuated between avoiding and facing the truth about their medical condition(75). Many of them 
also considered maintaining independence and withholding emotions to contribute to a good death, 
as this was perceived to minimise strain on their loved ones. 
In six studies, we identified several sociodemographic and functional patient characteristics 
that might affect self-management of patients with advanced cancer. These results were derived from 
non-experimental quantitative studies with moderate sample sizes and limited adjustments for 
confounding and selection bias, and should thus be interpreted cautiously. Nevertheless, they provide 
some explorative insights that could generate hypotheses for future research. Younger patients and 
patients with higher levels of physical functioning might, for instance, be more likely to adopt 
physically and socially active self-management strategies (e.g. yoga, physical exercise, participation in 
cancer support groups) than older patients and patients with lower levels of physical 
functioning(43,56). Another study suggested that fewer depressive symptoms, higher educational 
levels(57) and greater self-efficacy(57) positively predicted self-perceived effectiveness of applied self-
management strategies(57). Resigned acceptance and negative mood were also associated with more 
self-management difficulties(38). One of the explanations could be that patients with more depressive 
symptoms and a negative mood lack motivation and energy to actively self-manage(79). In addition, 
higher educated patients are generally more health literate(80), and might therefore be more likely 
than lower educated patients to take a proactive approach in self-management and acquire accurate 
knowledge and understanding of their condition and self-management possibilities(16,81). 
Furthermore, patients with higher self-efficacy levels are more likely to perceive symptoms and other 
disease consequences as modifiable and might therefore invest more in self-management strategies 
than patients with lower self-efficacy levels(82). 
Only three qualitative studies assessed attitudes of healthcare professionals towards patient 
self-management(53,55). Healthcare professionals in these studies were generally optimistic about 
patient self-management, but also set conditions for its effectiveness, such as solid patient-
professional partnerships and sufficient skills, knowledge and information. Suggestions to provide 
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patients with more education, introduced early in the disease trajectory and in a range of different 
formats, are in line with remarks made by nurses participating in a recent online focus group study on 
self-management support and eHealth for patients and relatives confronted with advanced 
cancer(83). We identified a lack of studies among relatives, and inconsistencies regarding the roles 
and responsibilities assigned to others (i.e. healthcare professionals, relatives) in the self-management 
definitions provided by some of the included studies. Nevertheless, our findings evidently show that 
important others play a crucial role in patient self-management, and should thus somehow be 
involved in self-management support. However, also fears of becoming a burden to relatives were 
commonly described by patients in our review as well as in previous studies(84,85). Together with 
findings that some patients appreciated each other’s company and derived satisfaction from 
participation in cancer-related charity activities, this suggests that peer support could be a promising 
pillar in patient self-management. The mutual benefits of peer support are increasingly recognised, 
also among patients with advanced cancer(86,87). 
 
Strengths and limitations 
To our knowledge, this is the first systematic review on patient self-management in advanced cancer 
care that includes perspectives of both patients and healthcare professionals. A strength is that we 
used a comprehensive search strategy with a broad operational definition of self-management. 
Nevertheless, we may have missed studies reporting on self-management without labelling it as such 
(or as a related term, e.g. self-care). The moderate quality of some of the included individual studies 
affected the evidential value of this systematic review, especially regarding selection bias: patients 
who had participated in the included studies may have been more able and willing to engage in the 
self-management strategies studied. This may have caused an overestimation of the prevalence and 
impact of self-management strategies. 
 
Relevance for clinical practice 
Our review provides several clinically relevant insights into self-management in the context of 
advanced cancer. Compared to care provided by healthcare professionals, patients’ self-management 
strategies may be substitutional (such as self-administering pain medications at home), additional and 
distinctive (such as mobilising peer support) or even conflicting (such as refraining from taking 
prescribed medications). This highlights the importance of solid patient-professional partnerships, in 
which preferences, experiences and expertise are mutually shared. Our review also provides a 
foundation for the development of self-management support interventions. Such programmes should 
be tailored to the domains in which patients need additional support. The findings on 
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sociodemographic and functional characteristics associated with self-management strategies also 
provide useful preliminary targets for self-management support programmes. For example, patients 
with low levels of education may need additional support in self-management domains of information, 
and navigation and coordination. Finally, a key challenge in the development of self-management 
support programmes will be to incorporate them into existing models of care(19). 
 
Implications for future research 
To enhance conceptual clarity regarding self-management in the advanced cancer context, we 
recommend consistency in terminology used as well as further elaboration of its definition and 
conceptual framework. Given the important role of formal and informal caregivers in supporting 
patient self-management, additionally, we recommend that future studies identify their experiences 
and attitudes as well. Finally, we recommend that future studies investigate the effectiveness and 
working mechanisms of self-management strategies used by patients with advanced cancer at the 




This systematic review shows that self-management of patients with advanced cancer is complex and 
multifaceted, covering multiple domains and a broad range of strategies and experiences that are 
highly dependent on individual preferences and characteristics. Possibly, the prospect of imminent 
deterioration and death adds to its complexity, as subsequent changes in values, priorities, interests 
and social interactions are likely to affect self-management strategies and experiences. Therefore, 
self-management support programmes for this vulnerable group could benefit from an individualised 
approach that re-evaluates patients’ needs and wishes, is embedded in solid partnerships with 
relatives and healthcare professionals, and is incorporated into existing models of care. 
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Table 1. Search terms. 
1 .Embase.com 
('advanced cancer'/de OR (((advance*) NEAR/4 (cancer* OR neoplas* OR carcinoma* OR tumor* 
OR tumour* OR malignan*))):ab,ti OR ((Neoplasm/mj/exp OR 'cancer patient'/de OR (neoplas* OR 
cancer* OR carcinoma* OR oncolog* OR tumor* OR tumour* OR malignan*):ab,ti) AND 
('metastasis'/exp OR 'palliative therapy'/exp OR 'palliative nursing'/de OR 'terminal care'/exp OR 
'terminally ill patient'/exp OR (metasta* OR palliati* OR terminal* OR 'end of life' OR hospice* OR 
incurable*):ab,ti))) AND ('self care'/exp OR 'self monitoring'/de OR 'drug self administration'/de 
OR (((self) NEXT/1 (car* OR help* OR manag* OR medicat* OR treat* OR monitor* OR 
administrat*))):ab,ti) NOT ('Conference Abstract'/it) 
2. Medline Epub (Ovid) 
(((advance*) ADJ4 (cancer* OR neoplas* OR carcinoma* OR tumor* OR tumour* OR 
malignan*)).ab,ti. OR ((exp* Neoplasms/ OR (neoplas* OR cancer* OR carcinoma* OR oncolog* 
OR tumor* OR tumour* OR malignan*).ab,ti.) AND (exp "Neoplasm Metastasis"/ OR "Palliative 
Care"/ OR "Palliative Medicine"/ OR "Hospice and Palliative Care Nursing"/ OR exp "Terminal 
Care"/ OR "Terminally Ill"/ OR (metasta* OR palliati* OR terminal* OR ((end) ADJ2 (life)) OR 
hospice* OR incurable*).ab,ti.))) AND (exp "Self Care"/ OR (((self) ADJ (car* OR help* OR manag* 
OR medicat* OR treat* OR monitor* OR administrat*))).ab,ti.) 
3. PsycInfo (Ovid) 
(((advance*) ADJ4 (cancer* OR neoplas* OR carcinoma* OR tumor* OR tumour* OR 
malignan*)).ab,ti. OR ((exp* Neoplasms/ OR (neoplas* OR cancer* OR carcinoma* OR oncolog* 
OR tumor* OR tumour* OR malignan*).ab,ti.) AND ("Metastasis"/ OR "Terminal Cancer" OR exp 
"Death and Dying"/ OR "Palliative Care"/ OR "Hospice"/ OR "Terminally Ill Patients"/ OR (metasta* 
OR palliati* OR terminal* OR "end of life" OR hospice* OR incurable*).ab,ti.))) AND (exp "Self 
Management"/ OR "Self-Monitoring" OR (((self) ADJ (car* OR help* OR manag* OR medicat* OR 
treat* OR monitor* OR administrat*))).ab,ti.) 
4. Cochrane Central 
((((advance*) NEAR/4 (cancer* OR neoplas* OR carcinoma* OR tumor* OR tumour* OR 
malignan*))):ab,ti OR (((neoplas* OR cancer* OR carcinoma* OR oncolog* OR tumor* OR tumour* 
OR malignan*):ab,ti) AND ((metasta* OR palliati* OR terminal* OR 'end of life' OR hospice* OR 
incurable*):ab,ti))) AND ((((self) NEXT/1 (car* OR help* OR manag* OR medicat* OR treat* OR 
monitor* OR administrat*))):ab,ti) 
5. Cinahl (EBSCO) 
(((advance*) N4 (cancer* OR neoplas* OR carcinoma* OR tumor* OR tumour* OR malignan*)) OR 
((MM Neoplasms+ OR MH "Cancer Patients" OR (neoplas* OR cancer* OR carcinoma* OR 
oncolog* OR tumor* OR tumour* OR malignan*)) AND (MH "Neoplasm Metastasis+" OR MH 
"Hospice and Palliative Nursing+" OR MH "Terminal Care+" OR MH "Terminally Ill Patients+" OR 
(metasta* OR palliati* OR terminal* OR "end of life" OR hospice* OR incurable*)))) AND (MH "Self 
Care+" OR (((self) N1 (car* OR help* OR manag* OR medicat* OR treat* OR monitor* OR 
administrat*)) OR (patient controlled N1 analgesi*))) 
6. Web of Science 
TS=(((((advance*) NEAR/3 (cancer* OR neoplas* OR carcinoma* OR tumor* OR tumour* OR 
malignan*))) OR (((neoplas* OR cancer* OR carcinoma* OR oncolog* OR tumor* OR tumour* OR 
malignan*)) AND ((metasta* OR palliati* OR terminal* OR "end of life" OR hospice* OR 
incurable*)))) AND ((((self) NEAR/1 (car* OR help* OR manag* OR medicat* OR treat* OR 
monitor* OR administrat*))))) AND DT=Article 
7. Google Scholar 























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The incidence and impact of implantable cardioverter defibrillator shocks in 
the last phase of life: An integrative review 
 
Stoevelaar R, Brinkman-Stoppelenburg A, Bhagwandien RE, van Bruchem-Visser RL, Theuns DAMJ, 
van der Heide A, Rietjens JAC 
 







Although the implantable cardioverter defibrillator is successful in terminating life threatening 
arrhythmias, it might give unwanted shocks in the last phase of life if not deactivated in a timely 
manner. 
Aims 
This integrated review aimed to provide an overview of studies reporting on implantable cardioverter 
defibrillator shock incidence and impact in the last phase of life. 
Methods and results 
We systematically searched five electronic databases. Studies reporting on the incidence and/or 
impact of implantable cardioverter defibrillator shocks in the last month of life were included. Fifteen 
studies were included. Two American studies published in 1996 and 1998 reported on the incidence 
of shocks in patients who died non-suddenly: incidences were 24% and 33%, respectively, in the last 
24 hours, and 7% and 14%, respectively, in the last hour of life. Six American studies and one Danish 
study published between 1991–1999 reported on patients dying 
suddenly: incidences were 41% and 68% in the last 24 hours and 22–66% in the last hour. Four 
American studies and two Swedish studies published between 2004–2015 did not distinguish the 
cause of death: incidences were 17–32% in the last month, 3–32% in the last 24 hours, and 8% and 
31% in the last hour of life. Three American studies published between 2004–2011 reported that 
shocks in dying patients are painful and distressing for patients, and distressing for relatives and 
professional caregivers. 
Conclusion 
If the implantable cardioverter defibrillator is not deactivated in a timely manner, a potentially 
significant proportion of implantable cardioverter defibrillator patients experience painful and 








During the last phase of life, goals of care usually shift from prolonging life to maintaining quality of 
life.(1) Many patients with heart failure eventually die due to progression of their underlying heart 
condition, despite the many treatments that are currently available.(2) Whether certain life-sustaining 
treatments are still appropriate in this last phase of life is an important topic of discussion. The 
implantable cardioverter defibrillator (ICD) is one of these life prolonging treatments that may pose 
difficult dilemmas in the last phase of life. The ICD is currently the treatment of choice in patients who 
are at risk of sudden cardiac death because of ventricular arrhythmias.(3) In Europe, more than 85.000 
ICDs were implanted in 2013, based on 46 countries, mainly in Western Europe.(4) The number of 
new implants is still increasing, due to both an ageing population and expanding of the indication for 
ICD implantation, shifting from secondary prevention (implantation in patients that already have 
experienced life-threatening arrhythmias or aborted cardiac death) to primary prevention 
(implantation in patients with an elevated risk of arrhythmias or cardiac death who have not yet 
experienced such an episode).(5) 
Although the ICD is effective in prolonging life, it poses challenges to the patient, such as (fear 
of) experiencing painful shocks and feelings of helplessness, because of the unpredictable nature of 
the arrhythmia and subsequent shocks.(6) During the last phase of life, the benefits of the ICD may no 
longer outweigh these challenges and it may be important to discuss whether or not to deactivate the 
device.(1) However, such discussions can be challenging and complex for healthcare professionals, 
patients, and their relatives. 
It is however unclear to what extend ICD patients experience shocks in the last phase of life, 
and what the impact of these shocks is, specifically at the end of life, on the patient, the patient’s 
relatives and the professional caregivers. Therefore, the following research questions will be 
addressed: (a) what is the incidence of appropriate and inappropriate ICD shocks in the last phase of 
life?; and (b) what is the impact of ICD shocks in the last phase of life on patients, their relatives, and 




Data sources and search strategy 
Research questions, search strategy and inclusion criteria were specified in advance and documented 
in a  protocol. A search query was developed to identify relevant papers. In August 2016, we 





of Science and Google Scholar. In order to find all relevant literature, we did not place a limitation on 
year of publication, all articles up to August 2016 were considered for inclusion. Studies were 
identified with the following keywords: defibrillator, defibrillator pacemaker, implantable cardioverter 
defibrillator, internal defibrillator, ICD, AICD; and shock, electric shock, electroshock, countershock, 
cardioversion, convulsive therapy; and terminal care, terminally ill patient, EOL, death, dying, 
palliative, hospice, last phase, last year, last month, last week, last day. Boolean  operators were used 
in between key words. The detailed search queries can be found in Supplementary Material Appendix 
1. 
 
Study selection and eligibility criteria 
Articles were reviewed by RS and AB via a stepwise procedure according to the PRISMA guidelines.(7) 
First, studies were screened on title and abstract. Selected studies were subsequently reviewed on 
full text and either included or excluded. In case of disagreement, consensus was sought and achieved. 
Table 1 describes the inclusion and exclusion criteria. Studies were included when they reported on 
deceased patients with an active ICD in the last phase of life, either on the incidence of ICD shocks or 
on the impact of shocks on patients, relatives or professional caregivers. The last phase of life was 
operationalised as the last month preceding death. This was based on a study that reported on shocks 
one month before death.(8) Relatives were not limited to family members but could also include 
others, such as close friends or other loved ones. Studies had to be written in English, and the full-text 
of the article had to be available. Studies were excluded when they reported on minors or were case 
reports. References lists from the included studies were examined to identify additional relevant 
studies. 
 
Table 1. Inclusion and exclusion criteria. 
Inclusion criteria 
1. Studies are empirical (both quantitative and qualitative) and report on deceased ICD 
patients that had an active ICD in the last month preceding death. 
2. Studies report on the incidence and/or impact of ICD shocks in the last month preceding 
death. 
3. Studies are in English. 
 
Exclusion criteria 
1. Studies in minors (<18 years of age). 
2. Study is a case report. 
3. Full text unavailable. 










Data of the studies that were included in the review were extracted via an extraction form. This form 
was  developed by RS, AB and JR and piloted by RS and AB. The eventual data extraction was 
completed by RS. 
The following data were extracted: 
1. Shock incidence, where possible stratified by type of death. Type of death could be non-
sudden death (NSD), defined as death occurring more than one hour after the onset of new 
symptoms, or sudden death (SD), defined as death that occurs less than one hour after the 
onset of new symptoms.(9) Shock incidence was calculated by dividing the number of patients 
in a specific group receiving shocks by the total number of patients in that group. 
2. Timing of shocks, categorised in three time periods: the last month, the last 24 hours and the 
last hour  preceding death. When a study reported on multiple time periods, patients who 
experienced shocks during the last hour or last 24 hours preceding death were also included 
in the incidence in the last 24 hours and last month before death. 
3. Appropriateness of shocks. An appropriate shock was defined as a shock for ventricular 
tachycardia (VT) or ventricular fibrillation (VF). An inappropriate shock was defined as any 
shock not delivered for VT or VF. 
4. Impact of shocks on either patients, relatives, or professional caregivers. All available data 
were extracted. 
5. Characteristics of the study, such as year of publication, study design, aim, year of 
implantation, year of death, and characteristics of the participants. 
 
Quality assessment 
Methodological quality was assessed with the Quality Assessment Tool.(10) Via this tool, studies were 
evaluated regarding nine items: abstract and title, introduction and aims, methods and data, sampling, 
data analyses, ethics and bias, results, generalisability, and implications. Each criterion was scored on 
a four-point Likert scale, ranging from one (very poor) to four (good). In total, a summed score of 9–
36 was calculated (9=very poor, 36=good). Studies with scores between 30–36 were assessed as high 
quality, studies with scores between 24–29 were assessed as moderate quality, and scores lower than 
23 were assessed as low quality. Studies were not excluded based on their methodological quality. 
 
RESULTS 
The search yielded a total of 4246 studies. We removed 1875 duplicates. All titles and abstracts were 





studies (see Figure 1), comprising a total population of 1362 (range 4–558) patients. All studies were 
observational. The majority of the studies were conducted in the USA (12), the remainder in Europe 
(three). A total of 12 studies reported solely on shock incidence (80%), two solely on the impact of 
shocks (13%) and one on both the incidence and impact of shocks (7%) (see Table 2). Studies scored 
moderate to high on methodological quality (Tables 3 and 4). No additional studies were identified 
after examination of the reference lists of the included articles. 
 
 
Figure 1. Flow diagram of literature search to identify articles reporting on the incidence and/or 









Table 2. Characteristics of the included studied (n = 15) 
Study characteristics  n (%) 
Type of study Quantitative 15 (100%) 
Country USA 12 (80%) 
 Sweden 2 (13%) 
 Canada 1 (7%) 
 Denmark 1 (7%) 
 New Zealand 1 (7%) 
Study on Shock incidence 13 (87%) 
 Impact 3 (20%) 
Number of patients in 
study 
0-50 7 (47%) 
 50-100 7 (47%) 
 >100 1 (7%) 
 
Incidence of ICD shocks 
A total of 13 studies reported on shock incidence (Table 3). The year of publication ranged from 1991–
2015. A prospective and a retrospective study, both high quality studies published in 1996 and 1998, 
reported on shock incidence in NSD patients.(11, 12) All deaths were of cardiac origin. In these studies, 
24% and 33% of patients respectively experienced one or more shocks in the last 24 hours, and 14% 
and 7% experienced one or more shocks in the last hour preceding death. One study reported on the 
appropriateness of the shocks,(12) and found that all shocks were appropriate. 
Seven studies reported on shock incidence in SD patients.(11-17) Year of publication ranged 
from 1991–1999. Studies scored moderate to high on methodological quality. All deaths were cardiac 
of origin. Two studies reported on shock incidence in the last 24 hours preceding death,(11, 12) one 
prospective study showed an incidence of 41%, a retrospective study showed an incidence of 68%. All 
seven studies reported on shock incidence in the final hour of life, showing an incidence ranging from 
22–66%. One study reported on the appropriateness of the shocks,(16) and found that all shocks were 
appropriate. 
Two studies from 1996 and 1998 specifically reported on patients dying of noncardiac 





shocks in the last 24 hours, and 8% experienced a shock in the last hour preceding death.(11) The 
second 

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In six studies, the type of death was not specified.(8, 18-22) Year of publication ranged from 
2004–2015 and all studies scored moderate to high on methodological quality. Three of these studies 
reported that 17–32% of patients experienced shocks in the last month of life.(8, 19, 21) Four studies 
showed that in the last 24 hours of life, 3–32% of patients experienced shocks.(18-20, 22) Two studies 
showed that in the last hour of life, 8% and 31% of patients experienced shocks.(8, 20) Two studies 
reported on the appropriateness of the shocks.(20, 22) In one study, all shocks were appropriate.(22) 
In the other study,(20) four of the 31 patients (13%) receiving shocks in the last 24 h were shocked 
inappropriately. 
 
Impact of ICD shocks 
A total of three studies reported on the impact of shocks in the last phase of life (Table 4). Date of 
publication ranged from 2004–2011. All studies were quantitative.(8, 23, 24) 
 
Impact of shocks on patients 
Two studies reported on the impact of shocks on patients in the last phase of life.(23, 24) In these 
studies, physicians and hospice administrators were surveyed. In the first study, physicians were asked 
whether they thought shocks are distressing to the patient. Seventy-six per cent agreed with this 
statement.(23) In the second study, hospice administrators reported that 74% of patients receiving 
shocks in the last phase of life were distressed by these shocks.(24) 
 
Impact of shocks on relatives 
Three studies reported on the impact of shocks on relatives.(8, 23, 24) In one study,8 100 next of kin 
were surveyed. The next of kin who witnessed the patient being shocked at the end of life reported 
that this was distressing to see. One relative reported in an interview that the patient experienced 
shocks every 20 minutes at the end of life, and reported it was like seeing the patient wake up from a 
‘really bad dream type of thing’, after which the patient lost consciousness again. In a survey study, 
76% of physicians agreed with the statement that shocks in patients at the end of their lives are 
distressing for the patients’ loved ones.(23) A study in hospices reported that 92% of family members 
of patients receiving shocks found this distressing to witness. In one case, a patient experienced shocks 
during the dying process and, immediately after, the nurse had to wrap her body around the patient 





























































































































































































   

















































































































































































































































































































































































































































































































































































































Impact of shocks on professional caregivers 
One survey study reported on the impact of shocks on professional caregivers.(24) Shocks were not 
only distressing for the hospice team to witness, but they must also deal with pain and panic induced 
by the shocks and loss of control in the patient and family. In the study, a situation was reported by a 
hospice administrator in which a patient was shocked multiple times during dying. The body was lifted 





This review suggests that shocks in the last month of life are common in patients with active ICDs. An 
important finding of this review is that of patients dying non-suddenly, a quarter to a third experienced 
shocks in the last 24 hours of life. In patients dying suddenly, this was a third up to nearly 70%. The 
number of studies on the impact of shocks in the last month of life on patients, relatives and 
professional caregivers was limited, but they suggest that shocks are painful for the patient and 
distressing for patients, relatives and professional caregivers. 
While the shock incidences found in this review are rather high, we found some variation 
between studies. There are several possible explanations for this variation. First, studies reporting on 
SD patients seem to report higher shock incidences than studies reporting on NSD patients.(11-17) 
This is because patients in these studies mostly died of sudden cardiac causes, predominantly due to 
VT(14) or VF,(16) resulting in the ICD delivering shocks. In patients dying non-suddenly, death is less 
often the direct result of a tachyarrhythmia, but rather of the underlying heart disease or bleeding, 
resulting in the ICD intervening less often. Second, the indication for ICD implantation has shifted over 
time. Seven studies reported on patients who had their ICD implanted before the year 2000. In this 
period, ICDs were mainly implanted in patients for secondary prevention. These patients have a higher 
risk of recurrent VTs than patients with ICDs for primary prevention, leading to higher shock 
incidences.20 From 2006 onwards, primary prevention was more often the indication for implantation 
than secondary prevention.(25) Only one study solely reported on patients with ICDs for primary 
prevention, showing that in the last 24 hours of life, 31% of patients experienced a shock.(22) This is 
still high, which might be due to the fact that in this particular study, patients with known sustained 
VT were excluded from the study, and only a single zone of therapy was used, so no antitachycardia 
pacing (ATP) was allowed. Third, in recent years, advances have been made to further optimise ICD 
programming to minimise inappropriate and appropriate therapy.(26) Developments such as ATP, 
longer detection times and high rate cut-offs all contribute to a reduction in shock therapy, by allowing 





programming the ICD could mean that the current incidence of shocks might be lower than reported 
in the studies in this review. Fourth, studies we found were mainly concerned with patients dying of 
cardiac diseases, which might be an explanation for the high incidences as well. Only two studies 
specifically reported shock incidences on patients dying of noncardiac causes. Incidence in these 
populations seem to be lower than in the populations of NSD and SD patients. 
Few studies were conducted on the impact of ICD shocks on patients in the last phase of life, 
their relatives and professional caregivers. From the literature on patients in earlier stages in their 
disease, it is known that shocks are painful and are associated with a diminished self-reported physical, 
emotional and social functioning, and symptoms of anxiety.(28) Although we found little detailed 
information on the impact of shocks in the last phase of life, this could also be the case in dying 
patients. In order to promote a peaceful death, quality of life should be pursued and the risk of 
developing symptoms of anxiety and depression should be reduced to a minimum. Timely deactivation 
of the ICD could help in promoting this peaceful death. 
Communication between the professional caregiver and patient might be an important factor 
in preventing unwanted shocks at the end of life by deactivating the ICD. It has been shown that, when 
deactivation is discussed, a large proportion of patients decide to do so.(8) However, these 
conversations are rare.(29, 30) Professional caregivers often struggle with these conversations, 
because they feel they have insufficient knowledge about end of life care,(31) they feel uncomfortable 
discussing the topic,(32) or because they think talking about deactivation would take away hope from 
the patient.(33) A stronger collaboration with palliative care professionals might help professional 
caregivers to feel less uncomfortable initiating discussions about end of life.(34, 35) Also, policies can 
be developed for caregivers who do not frequently attend ICD patients, explaining the importance of 
discussing and deactivating the ICD, with specific opening questions to address the topic.(1, 36, 37) 
More attention should be paid to inform the patient about the possibility of ICD deactivation, 
preferably starting before implantation of the device. Such discussions should be tailored to the 
patients’ health literacy, communication style and personal values. Physicians and nurses should be 
trained to obtain the necessary skills to discuss delicate end-of-life issues, such as possible 
deactivation of ICDs.(38) 
This study has some limitations. As with any review, it is possible that relevant studies were 
missed in conducting the search. In addition, publication bias is a possible limitation as well, leading 
to finding only articles which show notable results.7 Also, included studies had relatively small study 
populations, only three included more than 100 participants.(11, 12, 23) Further, seven of the 13 





currently be lower than reported in this review, as described above. Finally, the majority of the studies 
were conducted in the USA, which might reduce the generalisability to a European population. 
Future research on ICD management in the last phase of life should focus on determining 
shock incidences in both patients dying of noncardiac causes and patients dying with ICDs implanted 
for primary prevention, since these are not well known. Also, few studies are conducted on the impact 
of shocks at the end of life on patients, relatives and professional caregivers. This is a topic to be 
further examined. Also, it should be further examined what can be done to promote discussions 
before implantation and in early stages of the disease. 
 
CONCLUSIONS 
This is the first integrated review on the incidence and impact of ICD shocks in the last phase of life, 
providing a thorough overview of all the available evidence on these topics. Shocks were found to 
occur commonly, both in patients dying non-suddenly and patients dying suddenly. Shocks are painful 
and distressing for patients, but also distressing to witness for relatives and professional caregivers. 
The evidence summarised in this review should raise awareness among healthcare professionals of 
the negative consequences of having an active ICD at the end of life. Our findings emphasise that it is 
important for healthcare professionals to discuss ICD deactivation with the patient in an early stage 
of the disease. This can contribute to a timely deactivation of the ICD, and therefore can minimise 
possible suffering due to shocks and help promote a calm and peaceful death. 
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Supplementary Appendix 1. Detailed search queries for all databases. 
I. Embase 
('defibrillator'/de OR 'defibrillator pacemaker'/de OR 'implantable cardioverter defibrillator'/de OR 
'internal defibrillator'/de OR (((implant* OR intern* OR pacemaker* OR therap*) NEAR/4 
defibrillator*) OR ICD OR AICD):ab,ti) AND ('convulsive therapy'/de OR 'electric shock'/de OR 
'cardioversion'/de OR (shock OR shocks OR electroshock* OR countershock* OR cardioversion* OR 
cardioconversion* OR electroversion* OR electroconversion*):ab,ti) AND ('terminal care'/exp OR 
'terminally ill patient'/exp OR (terminal* OR ((end OR last) NEAR/4 (life OR living OR stage)) OR EOL 
OR death* OR dying* OR palliati* OR hospice* OR (last NEXT/1 (phase OR year* OR month* OR 
week* OR day*))):ab,ti) AND English:la NOT ('conference abstract'/it) 
 
II. Medline 
("Defibrillators, Implantable"/ OR (((implant* OR intern* OR pacemaker* OR therap*) ADJ4 
defibrillator*) OR ICD OR AICD).ab,ti.) AND ("Electric Countershock"/ OR (shock OR shocks OR 
electroshock* OR countershock* OR cardioversion* OR cardioconversion* OR electroversion* OR 
electroconversion*).ab,ti.) AND (exp "Terminal Care"/ OR "Terminally Ill"/ OR (terminal* OR ((end 
OR last) ADJ4 (life OR living OR stage)) OR EOL OR death* OR dying* OR palliati* OR hospice* OR 
(last ADJ1 (phase OR year* OR month* OR week* OR day*))).ab,ti.) AND English.lg. NOT 
(abstract).pt. 
 
III. Cochrane Central 
((((implant* OR intern* OR pacemaker* OR therap*) NEAR/4 defibrillator*) OR ICD OR AICD):ab,ti) 
AND ((shock OR shocks OR electroshock* OR countershock* OR cardioversion* OR 
cardioconversion* OR electroversion* OR electroconversion*):ab,ti) AND ((terminal* OR ((end OR 
last) NEAR/4 (life OR living OR stage)) OR EOL OR death* OR dying* OR palliati* OR hospice* OR 
(last NEXT/1 (phase OR year* OR month* OR week* OR day*))):ab,ti) 
 
IV. Web of Science 
TS=(((((implant* OR intern* OR pacemaker* OR therap*) NEAR/4 defibrillator*) OR ICD OR AICD)) 
AND ((shock OR shocks OR electroshock* OR countershock* OR cardioversion* OR 
cardioconversion* OR electroversion* OR electroconversion*)) AND ((terminal* OR ((end OR last) 
NEAR/4 (life OR living OR stage)) OR EOL OR death* OR dying* OR palliati* OR hospice* OR (last 
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The implantable cardioverter defibrillator (ICD) might give unwanted shocks in the last month of life. 
Guidelines recommend deactivation of the ICD prior to death. 
Aims 
The aims of this study were to examine trends in time (2007–2016) in how and when decisions are 
made about ICD deactivation, and to examine patient- and disease-related factors which may have 
influenced these decisions. In addition, care and ICD shock frequency in the last month of life of ICD 
patients are described. 
Methods 
Medical records of a sample of deceased patients who had their ICD implanted in 1999–2015 in a 
Dutch university (n = 308) or general (n = 72) hospital were examined. 
Results 
Median age at death was 71 years, and 88% were male. ICD deactivation discussions increased from 
6% for patients who had died between 2007 and 2009 to 35% for patients who had died between 
2013 and 2016. ICD deactivation rates increased in these periods from 16% to 42%. Presence of do-
not-resuscitate (DNR) orders increased from 9% to 46%. Palliative care consultations increased from 
0% to 9%. When the ICD remained active, shocks were reported for 7% of patients in the last month 
of life. Predictors of ICD deactivation were the occurrence of ICD deactivation discussions after 
implantation (OR 69.30, CI 26.45–181.59), DNR order (OR 6.83, CI 4.19–11.12), do-not-intubate order 
(OR 6.41, CI 3.75–10.96), and palliative care consultations (OR 8.67, CI 2.76–27.21) 
Conclusion 
ICD deactivation discussions and deactivation rates have increased since 2007. Nevertheless, ICDs 







The implantable cardioverter defibrillator (ICD) is effective in terminating life-threatening cardiac 
arrhythmias by giving electric shocks(1). When death is imminent due to irreversible terminal illness, 
shocks might be unwanted and can be a factor of distress to the patient and his or her family that 
disturbs the dying process(2).  
A recent integrated review using a systematic approach shows that ICD shocks occur rather 
frequently on the last day of life, ranging from 24% to 33% in patients who die nonsuddenly up to 41-
68% in patients who die suddenly(2). However, 7 of 13 studies in this review were conducted two 
decades or more ago, and studies were mainly based on patients with a secondary prevention 
indication, who are more prone to experiencing shocks due to their cardiac history(3). 
Important developments in ICD management have taken place. First, international expert 
consensus statements on the management of the ICD in the last phase of life have been published(1, 
4-6). In these statements it is discussed that shocks in the last phase of life may be physically and 
psychologically stressful, and it is recommended to deactivate the ICD at the end of a patient’s life(1). 
It is also recommended that professional caregivers have early and recurring discussions on the 
possibility and desirability of deactivating the ICD. These statements might have established an 
increase in ICD deactivation discussions and actual deactivation. Second, ICD programming has been 
further optimized. A longer detection time and a higher rate cutoff have shown good results in 
reducing the number of inappropriate shocks(7, 8). This might have established a decrease in patients 
receiving shocks at the end of life. 
The aims of this study were to: 
 
1. Examine the decision-making process concerning ICD deactivation and to examine 
patient- and disease- related factors influencing the decision to deactivate. 
2. Describe the care and ICD shock frequency in the last month of life of ICD patients, in 
particular the presence of do-not-resuscitate (DNR) and do-not-intubate (DNI) orders and 
the involvement of palliative care teams. 
 









Patients and setting 
Patients older than 18 years of age, who had an ICD implanted in a large Dutch university hospital or 
in a general hospital and who died between 2007 and 2016 were eligible for inclusion in the study. In 
the university hospital, a total of 544 patients with an ICD had died in the specified time period. These 
patients had their first ICD implanted between 1999 and 2015. Medical records of 25 deceased 
patients per year of implantation were randomly selected to be assessed for this study in order to 
obtain a representative sample that covered all years of implantation. If there were less than 25 
deceased patients for an implantation year, all patients were included. A total of 308 patients in the 
university hospital were eventually included. In the general hospital, 72 patients had died. These 
patients had their ICD implanted between 2002 and 2015 and all were included. 
 
Data collection 
Data were collected by AB, RS and AD from three sources: 
1. ICD registries in both hospitals contained clinical information, demographics, and ICD-related 
information such as indication for implantation, categorized as primary (implantation in 
patients with elevated risk of arrhythmias or cardiac death) or secondary prevention 
(implantation in patients who already experienced life-threatening arrhythmias or aborted 
cardiac death)(3), implantation date, type of ICD and occurrence of shocks in the last month 
of life, categorized as appropriate (shock for ventricular fibrillation or ventricular tachycardia) 
or inappropriate (any other shock). 
2. From the electronic and paper medical records we extracted the following data: the number 
and timing of ICD deactivation discussions, the presence DNR and DNI orders, consultations 
with palliative care teams (both hospitals had such a team), reasons for consultation, 
occurrence and characteristics of  ICD deactivation, and occurrence and timing of shocks. A 
checklist was developed and pilot tested in 10 patients by RS and AB.  
3. If a patient had died outside hospital, we contacted the patient’s general practitioner by 
telephone to collect data on the cause and place of death, whether or not the ICD was 
deactivated preceding death, and the occurrence of shocks in the last month of life.  
Cause of death was classified by RS and DT in four categories, using and adapted version of the 
classification schemes of Hinkle and Thaler and Epstein et al.(9, 10): sudden cardiac death – cardiac 
death that occurs within 1 h after the onset of new symptoms; nonsudden cardiac death – cardiac 





other causes; and unknown. Our study conforms with the principles outlined in the Declaration of 
Helsinki(11). Approval of the local ethical committee (METC-2016-453) was obtained before starting 
the data collection. 
 
Data analysis  
Descriptive statistics were used to summarize demographic data. Mean scores and standard 
deviations were calculated for normally distributed data and medians and interquartile ranges (IQRs) 
for non-normally distributed data. Differences in medians between patients dying during 2007-2009, 
2010-2012, and 2013-2016 were examined with Kruskal Wallis-tests. Categorical variables were 
compared with the Pearson Chi-square test, using a Bonferroni correction when appropriate. 
Differences between the two hospitals participating in this study were explored with Pearson Chi-
square tests. Logistic regression analyses were conducted for the variables that were expected to 
possibly predict deactivation of the ICD(12): age, gender, New York Heart Association (NYHA) 
classification, myocardial infarction, diabetes mellitus, chronic kidney disease, left ventricular ejection 
fraction (LVEF), indication for ICD implantation (primary vs. secondary prevention), occurrence of ICD 
discussion (no discussion vs. discussion before implantation vs. discussion after implantation), 
occurrence of palliative care team consultation (yes vs. no), presence of DNR and DNI order (yes vs. 
no), the occurrence of shocks (yes vs. no), and the year of death (divided in periods 2007-2009, 2010-
2012, 2013-2016). A p-value of <0.05 was used to indicate statistical significance. Analyses were 





Of the 380 patients examined in this study, 333 (88%) were male. Of patients, 110 had their first ICD 
implanted before 2005 (24 (22%) for primary prevention), 137 patients between 2005 and 2010 (95 
(69%) for primary prevention), and 133 patients after 2010 (99 (74%) for primary prevention). There 
was an increase in ICDs being implanted for primary prevention (p < 0.01) Patients had their first ICD 
implanted at a median age of 67 (IQR 58-73) years. After 2010, ICDs were implanted more frequently 
in older patients (median age at implantation 70 years) as compared to before 2010 (median age at 
implantation 65 years) (p < 0.01). Also, more ICDs were implanted for primary prevention in the 
general hospital (78%) compared to the university hospital (53%) (p < 0.01).  
Patients died at a median age of 71 (IQR 63-78), due to nonsudden cardiac causes (n=122, 





patients, cause of death was unknown. A total of 183 (48%) patients died in the hospital, 85 (22%) at 
home, and 30 (8%) in a facility (including nursing home and inpatient hospice).  
 
Table 1. Characteristics of ICD patients. 
 2007-2009 
(n = 96) 
2010-2012 
(n = 108) 
2013-2016 
(n = 176) 
All 
(n = 380) 
p-valuea 
Gender (Male) 89 (93%) 90 (83%) 154 (88%) 333 (88%) 0.13 
Age at ICD implantation 
(median, IQR) 
67 (58-73) 65 (57-72) 68 (59-74) 67 (58 – 
73) 
0.14 
Implantation for primary 
prevention 
38 (40%) 57 (53%) 123 (70%) 218 (57%) <0.01 
Type of ICD at first implant     0.35b 
   Single chamber 31 (32%) 30 (28%) 41 (23%) 102 (27%)  
   Dual chamber 37 (39%) 39 (36%) 61 (35%) 137 (36%)  
   CRT-D 28 (29%) 36 (33%) 69 (39%) 133 (35%)  
   Subcutaneous ICD 0 1 (1%) 4 (2%) 5 (1%)  
   Unknown 0 2 (2%) 1 (1%) 3 (1%)  
Type of ICD at death     0.26 b. 
   Single chamber 27 (28%) 31 (29%) 35 (20%) 93 (25%)  
   Dual chamber 37 (39%) 32 (30%) 54 (31%) 123 (32%)  
   CRT-D 31 (32%) 41 (38%) 81 (46%) 153 (40%)  
   Subcutaneous ICD 0 1 (1%) 4 (2%) 5 (1%)  
   ICD extracted 1 (1%) 1 (1%) 2 (1%) 4 (1%)  
   Unknown 0 2 (2%) 0 2 (1%)  
NYHA     0.53b 
   Class I 6 (6%) 8 (7%) 21 (12%) 35 (9%)  
   Class II 59 (61%) 62 (57%) 88 (50%) 209 (55%)  
   Class III 27 (28%) 32 (30%) 44 (25%) 103 (27%)  
   Class IV 0 1 (1%) 1 (1%) 2 (1%)  
   Unknown 4 (4%) 5 (5%) 22 (13%) 31 (8%)  
Comorbidities      
   Myocardial infarction 65 (68%) 72 (67%) 105 (60%) 242 (64%) 0.31 
   Diabetes Mellitus 21 (22%) 28 (26%) 61 (35%) 110 (29%) 0.06 
   Chronic kidney disease 39 (41%) 48 (44%) 79 (45%) 166 (44%) 0.78 
LVEF (≤ 30) 54 (56%) 57 (53%) 94 (53%) 205 (53%) 0.64 
Age at death (median, IQR) 70 (62-76) 70 (61-78) 72 (64-79) 71 (63-78) 0.19 
Classification of death     0.82b 
   Nonsudden cardiac 28 (29%) 30 (28%) 64 (36%) 122 (32%)  
   Sudden cardiac 11 (12%) 15 (14%) 21 (12%) 47 (12%)  
   Noncardiac 24 (25%) 34 (32%) 63 (36%) 121 (32%)  
   Unknown 33 (34%) 29 (27%) 28 (16%) 90 (24%)  
Place of death     0.47b 
   Home 16 (17%) 22 (20%) 47 (27%) 85 (22%)  
   Hospital 44 (46%) 54 (50%) 85 (48%) 183 (48%)  
   Nursing home 2 (2%) 9 (8%) 15 (9%) 26 (7%)  
   Hospice care 0 1 (1%) 3 (2%) 4 (1%)  
   Otherc 2 (2%) 3 (3%) 2 (1%) 7 (2%)  
   Unknown 32 (33%) 19 (18%) 24 (14%) 75 (20%)  






Decision-making about ICD deactivation 
Discussions on ICD deactivation 
In 81 (21%) medical records, discussions between a professional caregiver and the patient on ICD 
deactivation were reported (Table 2). Sixty (16%) patients had one discussion with a professional 
caregiver, and 21 (6%) patients had more than one discussion (range 2-7). Twenty (5%) patients had 
the discussion as part of a “pre-implantation conversation” with an ICD nurse, all of which were held 
in the university hospital. For 13 of these patients, this was the only occurrence that a discussion on 
ICD deactivation was reported in the medical record. Sixty-eight (18%) patients had a discussion after 
ICD implantation, for 47 patients this was the only time deactivation was discussed. Seven (2%) 
patients had discussions both before and after implantation. A total of 37 (10%) discussions were held 
on the day of deactivation. For 25 (7%) patients, this was the only time deactivation was discussed. 
Fifteen (19%) patients who had a discussion about ICD deactivation, did not have their ICD 
deactivated. In patients who died between 2007-2009, discussions on ICD deactivation were reported 
in 6 (6%) medical records, compared to 13 (12%) for 2010-2012, and 62 (35%) for 2013-2016 (p < 0.01). 
 
Table 2. Characteristics of ICD deactivation discussions. 
 2007-2009 
(n = 96) 
2010-2012 
(n = 108) 
2013-2016  
(n = 176) 
All deaths 
(n = 380) 
p-valuea 
Discussions about ICD 
deactivation 
6 (6%) 13 (12%) 62 (35%) b. 81 (21%) <0.01 
   Before ICD implantation 0 0 20 (11%) 20 (5%) <0.01 
   After ICD implantation 6 (6%) 13 (12%) 49 (28%) 68 (18%) <0.01 
Number of days between 
discussion and ICD deactivation 
(median, IQR)c 
0 (0-1) 0 (0-3) 0 (0-1) 0 (0-1) 0.78d 
Number of days between 
discussion and death (median, 
IQR)c 
6 (3-32) 5 (1-72) 9 (2-66) 8 (2-55) 0.80d 
Note. IQR: Interquartile range. 
ap-values calculated with Pearson Chi-Square test. 
bSome patients had discussions both before and after ICD implantation. 
cOnly patients with discussions after ICD implantation (n = 68) were included in calculating medians. 
dDifference between medians calculated with Kruskal-Wallis test. 
 
  
IQR: Interquartile range; LVEF: Left ventricular ejection fraction; NYHA: New York Heart 
Association; CRT-D: Cardiac Resynchronization Therapy – Defibrillator; S-ICD: Subcutaneous ICD. 
ap-values calculated with Pearson Chi-Square test. 
bThe “unknown” category was not used in calculating the statistical significance of differences 
between groups. 
cOther places of death were: in the ambulance on the way to hospital (n = 2), in a rehabilitation 





Characteristics of ICD deactivation   
In 112 (30%) medical records, it was reported that the ICD was deactivated before death (Table 3). 
Sixty-six (59%) of these patients had a previous discussion about deactivation. ICD deactivation was 
performed through reprogramming the device for 70 (63%) patients, through placing a magnet for 15 
(13%) patients, and 4 (4%) devices were completely removed due to infections. For 23 (21%) patients, 
it was unknown how the ICD was deactivated. The ICD was mostly deactivated in the hospital in 92 
(82%) patients. Four patients had their ICD deactivated at home, three in a nursing home, one in an 
ambulance and one in a revalidation center. ICDs were mostly deactivated by ICD technicians (69 
patients, 62%) and cardiologists (10 patients, 9%). Deactivation was more rarely conducted by 
emergency physicians (n = 2), internists (n = 1), anesthesiologists (n = 1), oncologist (n = 1), and 
ambulance staff (n = 1). Patients’ median age at deactivation was 72 (IQR 65 - 78) years. Patients died 
a median of 3 (IQR 0 – 18) days after deactivation. In 15 (16%) patients who died between 2007-2009 
the ICD was deactivated, as compared to 24 (22%) deactivations in patients who died between 2010-
2012 and 73 (42%) who died between 2013-2016 (p < 0.01). 
 
Table 3. Characteristics of ICD deactivation. 
 2007-2009 
(n = 96) 
2010-2012 
(n = 108) 
2013-2016 
(n = 176) 
All years 
(n = 380) 
p-valuea 
Total number of deactivations 15 (16%) 24 (22%) 73 (42%) 112 (30%) <0.01 
Type of deactivation     0.39b 
   Reprogramming 11 (73%) 13 (54%) 46 (63%) 70 (63%)  
   Magnet 0 5 (21%) 10 (14%) 15 (13%)  
   Extraction 1 (7%) 1 (4%) 2 (3%) 4 (4%)  
   Unknown 3 (20%) 5 (21%) 15 (21%) 23 (21%)  
Location of deactivation     0.75b 
   Hospital 12 (80%) 17 (71%) 63 (86%) 92 (82%)  
   Home 0 0 4 (5%) 4 (4%)  
   Nursing home 0 1 (4%) 2 (3%) 3 (3%)  
   Otherc 0 0 2 (3%) 2 (2%)  
   Unknown 3 (20%) 6 (25%) 2 (3%) 11 (10%)  
ICD deactivated by     0.80b 
   Cardiologist 1 (7%) 3 (13%) 6 (8%) 10 (9%)  
   ICD technician 7 (47%) 12 (50%) 50 (68%) 69 (62%)  
   Otherd 0 1 (4%) 5 (7%) 6 (5%)  
   Unknown 7 (47%) 8 (33%) 12 (16%) 27 (24%)  
Age at deactivation (median, 
IQR) 
62 (57-71) 75 (68-80) 73 (66-78) 72 (65-78) 0.02e 
Number of days from 
deactivation to death 
(median, IQR) 
3 (0-23) 2 (0-24) 4 (1-17) 3 (0-18) 0.89e 
Note. Percentages may not add up to 100% due to rounding. 
IQR: Interquartile range. 





bThe “unknown” category was not used in calculating the statistical significance of differences 
between groups. 
cOther locations of deactivation were: in the ambulance on the way to the hospital (n = 1), in a 
revalidation center (n = 1). 
dOther persons who deactivated the ICD were: physician other than cardiologist (n = 5), 
ambulance staff member (n = 1). 
eDifference between medians calculated with Kruskal-Wallis test. 
 
Care and shocks in the last month of life 
DNR- and DNI-orders and palliative care teams 
In 120 (32%) medical records a DNR-order was documented (Table 4); this concerned 9 (9%) patients 
who died between 2007-2009, 30 (28%) patients who died between 2010-2012, and 81 (46%) patients 
who died between 2013-2016 (p < 0.01). In 78 (21%) medical records a DNI-order was documented; 
this concerned 5 (5%) patients who died between 2007-2009, 25 (23%) patients who died between 
2010-2012, and 48 (27%) patients who died between 2013-2016 (p < 0.01). Palliative care team 
consultations were documented in 17 (5%) medical records, all consultations occurred after 2010. 
Teams were consulted about medication management or the possible use of palliative sedation. In 
one case the team was consulted because of a euthanasia request. 
 
Occurrence of shocks 
A total of 268 (71%) patients died with an active ICD. In 114 (43%) of these medical records, one or 
more shocks were reported (Table 4). Of the patients who experienced one or more shocks, 89% 
experienced an appropriate shock, and 24% an inappropriate shock. In 20 (7%) medical records, shocks 
were reported in the last month of life (90% appropriate and 15% inappropriate) and in 5 (2%) on the 
last day of life (100% appropriate and in 20% inappropriate). Occurrence of shocks in the last month 
and on the last day of life did not significantly differ in patients dying between 2007-2009, 2010-2012 
or 2013-2016.  Of the patients who died with an active ICD, 71 (26%) deaths were classified as 
nonsudden cardiac, 39 (15%) as sudden cardiac, and 76 (28%) as noncardiac. For 82 (31%) patients, 
cause of death was unknown. In patients whose deaths were classified as sudden cardiac, shocks in 
the last month of life were significantly more often reported (28% shocks) as compared to patients 
whose deaths were described as nonsudden cardiac (4% shocks), noncardiac (3% shocks) or unknown 
(5% shocks) (p < 0.01). 
 
Table 4. Presence of DNR and DNI orders, palliative team consultations and shock incidence. 
 2007-2009 
(n = 96) 
2010-2012 
(n = 108) 
2013-2016 
 (n = 176) 
All deaths 
(n = 380) 
p-valuea 
Presence of DNR order 9 (9%) 30 (28%) 81 (46%) 120 (32%) <0.01 





Consultation with palliative 
care team 
0 2 (2%) 15 (9%) 17 (5%) <0.01 
Shocks 30 days before deathb 5 (6%) 6 (7%) 9 (9%) 20 (7%) 0.80 
Shocks 24 h before deathb 0 2 (2%) 3 (3%) 5 (2%) 0.32 
All shocksb 45 (56%) 31 (37%) 38 (37%) 114 (43%) 0.02 
Note. DNR: do-not-resuscitate; DNI: do-not-intubate. 
ap-values calculated with Pearson Chi-square test. 
bOnly patients with an active ICD at time of dying were included in these calculations: between 
2007-2009, n = 81; between 2010-2012, n = 84; between 2013-2016, n = 103. 
 
Predictors of ICD deactivation 
A total of 14 factors were examined to determine their relationship with ICD deactivation (Table 5). 
Significant predictors of ICD deactivation were the occurrence of ICD deactivation discussions after 
implantation (odds ratio (OR) 69.30, confidence interval (CI) 26.45-181.59), the presence of a DNR (OR 
6.83, CI 4.19-11.12) or DNI order (OR 6.41, CI 3.75-10.96), the occurrence of a palliative care team 
consultation (OR 8.67, CI 2.76-27.21), and year of death (OR 2.05, CI 1.51-2.78). 
 
Table 5. Clinical and nonclinical predictors of ICD deactivationa 
Predictor Variables OR 95% CI p-value 
Age 1 0.98-1.02 0.94 
Gender 0.70 0.37-1.34 0.28 
NYHA 1.05 0.72-1.54 0.79 
Myocardial infarction 0.98 0.62-1.55 0.94 
Diabetes Mellitus 0.92 0.56-1.50 0.72 
Chronic kidney disease 1 0.64-1.57 0.99 
LVEF (≤ 30) 1.33 0.85-2.08 0.21 
Indication (primary prevention) 1.38 0.88-2.18 0.16 
ICD discussions   <0.01 
   Before implantation 1.65 0.44-6.23 0.46 
   After implantation 69.3 26.45-181.59 <0.01 
DNR-order 6.83 4.19-11.12 <0.01 
DNI-order 6.41 3.75-10.96 <0.01 
Palliative care team consultation 8.67 2.76-27.21 <0.01 
Shocks 0.81 0.52-1.28 0.36 
Year of death 2.05 1.51-2.78 <0.01 
Note. OR: Odds Ratio; 95% CI: 95 percent confidence interval; NYHA: New York Heart Association; LVEF: 
Left ventricular ejection fraction; DNR: Do-not-resuscitate; DNI: Do-not-intubate. 




Decision-making about ICD deactivation 
In this study, discussions about ICD deactivation between professional caregivers and the patient were 





record, occurring after implantation of the device.  There was however a steep increase in discussions 
over the years, from 6% for patients dying between 2007-2009 up to 35% for patients dying between 
2013-2016. Discussing ICD deactivation was significantly associated with ICD deactivation, which was 
reported in 30% of the medical records overall, also with an increase over the studied years from 16% 
up to 42%. The increase in deactivation discussions and actual deactivation might be attributable to 
the increased attention to ICD management in the last phase of life, such as the development of expert 
consensus statements(1, 4-6), and more general to an increased attention to advance care 
planning(13). The percentages of deactivation discussion and deactivation are in line with a 
retrospective study conducted in the UK in patients (n = 44) who died in 2012 and 2013, showing that 
39% of patients had documentation of a discussion about ICD deactivation after implantation(12). A 
recent prospective American study in which 51 ICD  patients were prospectively followed showed that 
26% of the patients discussed the possibility of deactivation with their cardiologist(14). Two Swedish 
studies published in 2014 and 2015 showed that 30-49% of patients had their ICD deactivated(3, 15). 
Despite an increase in ICD deactivation discussions and actual deactivations, current rates are 
still rather low. Several factors may explain this. It might be possible that actual deactivation 
discussions were not reported in the hospital medical records(16), or that these discussions were 
described in another medical file by another professional caregiver (such as the general practitioner). 
It is however of utmost importance that conversations about this topic are reported in the medical 
record, so that other professional caregivers are aware of the knowledge level and preferences of the 
patient. Secondly, while studies show that many professional caregivers think that the possibility of 
future deactivation should be discussed in an early stage of the disease(17), other studies report on 
barriers on actually engaging in such discussions(17). Professional caregivers are often unsure about 
the right time to discuss deactivation(18), sometimes feel like they do not have a well enough 
established relationship with the patient(19), have too little time to accurately discuss 
deactivation(18), find it difficult to predict the end of life(20) or feel that talking about deactivation 
might be inappropriate, since the ICD was implanted to ‘safe lives’(19). Also, a recent international 
survey study from the UK, conducted in 262 professionals caregivers, shows that professional 
caregivers who are physicians or American, and had initiated a deactivation discussion before, were 
more likely to discuss ICD deactivation(21). This study also identifies that, even though only 30% of 
nurses were involved in ICD deactivation discussion, 81% of professional caregivers felt that nurses do 
have the necessary skills to start these conversations, and might therefore play a bigger role in 
informing patients about ICD deactivation. Further, the study identified that nurses were in favor of 
informing the patients about ICD deactivation before implantation, which is in line with current 





implantation, to make the patients aware of the consequences of having an active ICD at the end of 
life(1, 4, 6). 
Although the patient’s willingness to discuss ICD deactivation varies, previous studies showed 
that patients are sometimes hesitant to discuss ICD deactivation, or might even be unaware about the 
option of deactivation at all(22). Some patients may misunderstand the role and function of the 
ICD(17), the distinction between the bradycardia- and tachycardia therapy, and are not always sure 
why the ICD might intervene(23). Patients sometimes consider deactivation to be similar to the active 
ending of life(23). The active ending of life, or euthanasia, is however defined as medication 
administered by a physician, with the explicit intention of hastening death at the explicit request of 
the patient. Euthanasia is legal in the Netherlands, under strict criteria stipulated by the Dutch 
euthanasia law, and only allowed for patients who are suffering unbearably with no prospect on 
relief(24). Deactivating the ICD is fundamentally different from euthanasia, since no medication is 
administered to hasten death. Also, deactivating the ICD will not cause imminent death, contrary to 
what patients sometimes believe(25). It is important to inform patients about ICD deactivation 
adjusted to their willingness to engage in these conversations, their knowledge level, and stage of 
disease(13). 
 
Care and shocks in the last month of life 
In our study, DNR orders were present in 32% of medical records of deceased ICD patients, which is a 
significant increase since 2007, in which only 9% of patients had a DNR order. Discussing a DNR order 
has been suggested to be a good opportunity to also discuss possible ICD deactivation(1, 4, 6). 
Nevertheless, while in our study DNR orders were associated with ICD deactivation, almost half of the 
patients with a DNR order had an active ICD at time of death. A full advance care planning process 
including discussions between patients with an ICD, their next of kin and professional caregivers has 
been suggested to be a be more effective than merely the completion of a DNR order(13, 26). 
Palliative care teams were rarely consulted (5%), possibly because professional caregivers are 
unsure about the possible contribution of these teams to patient care(27). We did however see, that 
palliative care team consultations was associated with ICD deactivation. There is an unmet need for 
palliative care in patients with heart failure(28). Not all cardiologists consider end-of-life care to be 
part of their responsibility(29). Yet, palliative care teams can help to clarify goals of care of ICD 
patients, and might contribute to patient-centered end-of-life care(30). 
In patients in whom the ICD was not deactivated, shocks in the last month of life were reported 
in 20 (7%) patients and shocks in the last 24 hours were reported in 5 (2%) patients. Previous studies 





last 24 hours of life(2). This might be due to different factors, such as the high proportion of patients 
who have their ICD implanted for primary prevention in our study, which is the main indication for ICD 
implantation since 2006(31). Previous studies that reported on shock incidence are generally older 
and have high proportions of secondary prevention patients(3, 15). Furthermore, developments in 
optimizing ICD programming have resulted in reducing the number of inappropriate shocks at the end 
of life(7, 8). 
 
Strengths and limitations 
To our knowledge, this is the first study that examines the trends in time of ICD deactivation 
discussions, ICD deactivation and ICD shocks and that identifies factors which possibly predict ICD 
deactivation. Also, this is the largest study to examine shocks in the last month of life. This study does 
however have some limitations. This study was a retrospective study which relied on the medical 
records of patients. These medical records could be incomplete(16), which could have led to 
underreporting of discussions regarding ICD deactivation. Also, we did not have insight in the exact 
content of the deactivation discussions.  
  
Recommendations and future research 
Guidelines recommend that discussions on ICD deactivation occur early and on set times during the 
disease trajectory(1, 4-6). Educating patients about the consequences of an active ICD in the last phase 
of life is an important task for the health care professional and has been proven to increase device 
deactivation(23, 32). These discussions should include an extensive exploration of the patient’s 
personal values and future goals of care, and should frequently be reassessed, since patients might be 
subject to changing preferences(13). Professional caregivers might be supported in conducting these 
conversations by palliative care teams, and practical decision aids, such as checklists(30). 
Documentation of these discussions is crucial, and decisions should be communicated with all involved 
professional caregivers to avoid misunderstanding and enable good decision-making(5). Future 





The occurrence of ICD deactivation discussions, both before and after implantation, the number of 
ICD deactivations, the presence of DNR and DNI orders and the number of palliative care team 





at the end of life, who as a result may experience shocks. This study underlines the importance of 
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Implantable cardioverter defibrillators can treat life threatening arrhythmias, but may negatively 
influence the last phase of life if not deactivated. Advance care planning conversations can prepare 
patients for future decision-making about implantable cardioverter defibrillator deactivation. This 
study aimed at gaining insight in the experiences of patients with advance care planning conversations 
about implantable cardioverter defibrillator deactivation. 
Methods 
In this qualitative study, we held five focus groups with 41 patients in total. Focus groups were audio-
recorded and transcribed. Transcripts were analyzed thematically, using the constant comparative 
method, whereby themes emerging from the data are compared with previously emerged themes. 
Results 
Most patients could imagine deciding to have their implantable cardioverter defibrillator deactivated, 
for instance because the benefits of an active device no longer outweigh the harm of unwanted 
shocks, when having another life-limiting illness, or when relatives would think this would be in their 
best interest. Some patients expressed a need for advance care planning conversations with a 
healthcare professional about deactivation, but few had had these. Others did not, saying they solely 
focused on living. Some patients were hesitant to record their preferences about deactivation in 
advance care directives, because they were unsure whether their current preferences would reflect 
future preferences. 
Conclusions 
Although patients expressed a need for more information, advance care planning conversations about 
implantable cardioverter defibrillator deactivation seemed to be uncommon. Deactivation should be 
more frequently addressed by healthcare professionals, tailored to the disease stage of the patient 









The Implantable Cardioverter Defibrillator (ICD) treats potentially lethal arrhythmias by either 
antitachycardia pacing or delivering an electrical shock(1). About half of ICD patients experience 
potentially painful shocks during their life(2). The number of ICD patients has grown, as the indication 
for implantation has been extended from secondary to primary prevention(3). While the ICD is 
effective in treating arrhythmias, patients eventually die due to deterioration of their underlying heart 
disease or another illness(4). An active ICD delivers shocks in the last 24 hours of life in up to 33% of 
patients dying nonsuddenly(5). Shocks are potentially painful and a source of distress and anxiety for 
patients and relatives(5, 6). Shocks can be avoided by timely deactivating the shock function of the 
ICD(7). 
International expert consensus statements from the European Heart Rhythm Association and 
Heart Rhythm Society recommend to timely and repeatedly discuss ICD deactivation with the patient 
and relatives(1, 8). This is in line with the international advance care planning (ACP) consensus 
statement(9). ACP enables individuals to define and discuss goals and preferences for future medical 
treatment and care, and to record and review these if appropriate(9). Previous studies have shown 
that only a minority of patients (27% in a study from 2004(10), up to 35% in a study from 2018(2)) had 
discussed ICD deactivation with their healthcare professional and had their ICD deactivated prior to 
death(2, 11). It is unknown why ICD deactivation is infrequently discussed, and what patients would 
want with their device when approaching the end-of-life. It is known that many patients are confused 
about the role of the ICD, especially in the last stages of life(12, 13). 
Insight into the experiences of ICD patients with ACP conversations about ICD deactivation is 
limited. Having more insight into these experiences and on how ICD patients reflect on the end-of-life 
might help to increase the understanding of how patients think, and how they could best be 
approached in having an ACP conversation. Therefore, we examined ICD patients’ experiences with 




Study design and sample 
We conducted focus groups with ICD patients, recruited via the Dutch national ICD recipient 
association (“STIN”). A call for participants was published in their magazine, on their website and on 
social media channels. Patients were eligible when they had an active ICD, were older than 40 years, 





participating in the study received information via e-mail, accompanied with an informed consent 
form. Focus groups were organized in the Erasmus University Medical Center Rotterdam, the 
Netherlands. Patients were compensated for their time with a gift card of €25, and received 
reimbursement for travel expenses. 
Forty-one patients agreed to participate in the study. Five focus groups were organized with 
respectively 9, 8, 9, 9, and 6 patients. Approval of the study was obtained from the local research 
ethics committee (METC-2017-357). 
  
Data collection 
Focus groups were conducted in September 2017, and were led by senior researchers with experience 
in leading focus groups (AB, AH, JR), and supported by two researchers (RS or AB) who took field notes. 
Participants completed a questionnaire on demographic characteristics prior to the focus group. Focus 
groups were recorded and subsequently transcribed. Patients received a summary of the transcripts 
after the focus groups were conducted.  
An interview guide was used to guide the focus groups (Box 1). This semi-structured guide was 
developed by the research group, based on expert opinion and previously published literature(13, 14). 
Topics discussed were: 1) information provision and communication about the ICD at the end-of-life, 
2) attitudes towards ICD deactivation and 3) suggestions for improvement of information provision 
and communication. 
 
Box 1. Interview guide used to facilitate focus groups 
► Information provision and communication about the ICD at the end-of-life: 
– Did you ever had a conversation with your healthcare professional about what to do with 
your ICD when you get older or sick? What was discussed? 
– How do you value the quality of this conversation? 
– How would you prefer to get informed about the ICD at the end-of-life? 
► Attitudes towards ICD deactivation 
– Did you ever think about what to do with your ICD when you get older or sick? 
– Would you deactivate the device? Why (not)? 
► Points for improvement 
– Looking back at the conversation you had with your healthcare professional, are there things 
you would like to see improved? 
ICD, implantable cardioverter defibrillator 
 
Data analysis 
Transcript were analyzed thematically, using the constant comparative method, a data-analytic 
process whereby each interpretation and finding emerging from the data is compared with previous 
findings(15). Transcripts were read by JR and RS and meaningful themes were inductively identified 





tested on one of the transcripts, refined and finalized. Subsequently, all transcripts were coded by RS, 
and checked by JR. The two researchers met frequently to discuss the coded transcripts, and to discuss 
and resolve minor disagreements. 
 
Patient and Public Involvement 
A patient advisory group met frequently for the duration of the study and provided feedback on 





Focus groups lasted an average of 97 minutes (range 89-107). Patients were more often male (56%) 
and had a mean age of 64 (SD 9.7). A majority had their ICD implanted for primary prevention (59%), 
and 44% had a Cardiac Resynchronization Therapy – Defibrillator implanted, on average 6.4 (SD 4.8) 
years before participation in the study (Table 1). 
 The results are described along the line of the three key elements of ACP: 1) Reflection on 
wishes and preferences; 2) discussing preferences with healthcare professionals and relatives; 3) 
recording and reviewing preferences(9). Illustrative quotes per key element are presented in Table 2. 
 
Table 1. Characteristics of patients enrolled in the focus groups (n=41) 
Gender (male) 23 (56%) 
Mean age (SD) 64.3 (9.7) 
Marital status 
Unmarried 2 (5%) 
Married 30 (73%) 
Divorced 6 (15%) 
Widowed 3 (7%) 
Education 
Less than high school 1 (2%) 
High school graduate 10 (24%) 
Some college 8 (20%) 
College graduate 15 (37%) 
University degree 7 (17%) 
Indication for ICD (primary prevention) 24 (59%) 
Type of ICD 
Single chamber 9 (22%) 
Dual chamber 6 (15%) 
CRT-D 18 (44%) 
S-ICD 1 (2%) 
Unknown 2 (5%) 

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Reflection on wishes and preferences regarding future ICD deactivation 
Some patients were not aware that ICD deactivation was an option, and one patient thought he was 
not able to die with an ICD (Q1 in Table 2). Of those who were aware of ICD deactivation, wishes and 
preferences differed. Most could imagine deciding to have their ICD deactivated one day. However, 
some patients indicated they could not imagine ever asking for deactivation. One patient for instance 
indicated that deactivating the ICD could feel like “euthanasia”. Euthanasia, defined as ending a 
patient’s life by administering medication by a physician with the explicit intention of hastening death, 
at the explicit request of the patient, who suffers unbearably without prospect on relief, is legalized 
in the Netherlands under strict criteria stipulated by the Dutch law(16). Some patients were uncertain 
about in what situation deactivating their ICD would be appropriate, stating that the decision to 
deactivate is complex and dependent of multiple factors (Q2). 
Patients often considered the balance between quality versus length of life when reflecting 
on possible future ICD deactivation. This balance differed between people, but generally patients 
indicated that postponing death – just because it is possible – without taking quality of life into account 
does not make sense. The ICD was considered a lifesaving device by many patients, which was also 
apparent in how patients talked about their device. They often used words such as ‘angel’, ‘guard dog’ 
and ‘safety net’. However, some patients described a ‘love-hate’ relationship with their device: 
previous shocks had saved them from a sudden death, but were painful, often a source of concern, 
and a personal confrontation with being ill and the finiteness of life. The possibility of experiencing 
unwanted shocks while dying was often brought up as an important factor when reflecting on the role 
of the ICD at the end-of-life. One patient described that their fear of receiving shocks was greater than 
the fear of dying (Q3).  However, another patient indicated to always want arrhythmias to be treated 
by shocks, even if death was imminent (Q4). 
 Some patients stated that living longer with a compromised quality of life was undesirable. 
Losing independency and being diagnosed with a life-limiting illness were amongst the most 
frequently mentioned factors threatening quality of life. However, there was a distinction made in the 
nature of the disease. Advanced cancer or advanced lung disease was brought up by several patients 
as a clear indication to ICD deactivation, since an active ICD would potentially mean having to live 
longer with symptoms such as pain and discomfort, but, as one patient described, a progression of 
heart disease could make one hesitant about ICD deactivation (Q5). 
 Patients indicated that their relatives would play an important role in the decision-making 
about ICD deactivation. Several patients indicated that they did not want their relatives to witness 
them whilst receiving shocks at the end-of-life (Q6). On the other hand, some others mentioned that 







Although patients used different sources of information, including the internet and patient folders 
from the hospital, the preferred mode to receive information on ICD deactivation was by having 
conversations with the healthcare professional. Some patients had had this conversation, mostly with 
their general practitioner or cardiologist and on their own initiative. Such conversations gave relief to 
some patients (Q7). The vast majority of patients however, indicated they never had had such 
conversations, which was source of discontent among some patients (Q8). 
Patients described their cardiologist as very knowledgeable on a medical-technological level, 
but some indicated they felt there was not always the opportunity to discuss issues with a strong 
emotional component. Various reasons were suggested for this, such as a perceived lack of time or 
willingness of the cardiologist, as well as unawareness of importance of the healthcare professionals 
(Q9). These patients envisioned a greater role for other healthcare professionals to support the 
cardiologist in conducting these conversations, such as nurses or the general practitioner. 
There was debate on the timing of conversations about ICD deactivation. Some patients 
thought it was best to engage early in ACP conversations about ICD deactivation, starting before 
implantation. However, others felt that bringing up issues related to the end-of-life at this stage might 
be inappropriate, since implantation of the ICD felt like a ‘second chance at life’. Therefore, some 
suggested to start up such ACP conversations during follow-up visits. However, others disagreed, since 
patients might get worried about why the physician would bring up the topic at that particular 
moment. Other moments were also identified to discuss ICD deactivation: when faced with a life-
limiting illness, or when a do-not-resuscitate order is being discussed. 
 While most patients had positive attitudes towards discussing the end-of-life and ICD 
deactivation, this was not true for all patients. Some described they focused on living and getting 
better, and that they felt no need to think about future ICD deactivation (Q10). 
 Several patients mentioned that they had discussed possible future ICD deactivation with their 
relatives. Some considered such conversations to be more important than conversations with 
healthcare professionals. Most patients had positive experiences with talking with their relatives 
about ICD deactivation. Yet, some patients indicated that their relatives did not want to engage in 
such conversations (Q11). 
 
Recording and reviewing preferences 
Some patients had their preferences for future medical care and treatments recorded in an advance 





about ICD deactivation in a document, because they were not sure what they would want when their 
disease would progress. It was also described that, even if someone has well-considered ideas and 
whishes about what to do in specific situations, these ideas could be opposite of how someone acts 
when they are actually in that situation, and that people adapt to their current situation (Q12). They 
said that multiple factors influence the decision to deactivate, such as prognosis, age, and severity of 
illness. Also, they were doubtful whether their wishes would be respected. On the contrary, others 
were in favor of reporting their preferences about ICD deactivation in an advance care directive. One 
patient had an earlier experience with a loved one at the end-of-life, and indicated that an advance 




Little research has been conducted on the experiences of ICD patients with ACP conversations about 
ICD deactivation. Although international expert consensus statements recommend to timely and 
frequently discuss ICD deactivation with the patient(1), recent studies show these conversations are 
scarce(2). Several patients in our study indicated that their healthcare providers are capable regarding 
medical-technological issues, but felt there was not always the opportunity to discuss topics with an 
emotional component, such as the end-of-life. This was also shown in an American focus group study 
with nurses, where nurses stated that physicians sometimes ‘fail’ in considering psychosocial, 
economic, and ACP aspects of living with an ICD(14). Another American interview study with ICD 
patients showed that patients seemed to deprioritize ACP conversations, and overemphasize the 
lifesaving abilities of the ICD(17). In our study, we saw that some patients were unaware of the option 
of ICD deactivation. This lack of knowledge in the patient could decrease the willingness of ICD patients 
to engage in ACP and discuss deactivation(18, 19). A lack of ACP conversations might impair the 
decision-making at the end-of-life, leading to reactive decision-making concerning ICD 
deactivation(14). Several patients indicated that it is important to discuss ICD deactivation with their 
relatives. However, involving families could also cause conflicts, such as relatives wanting the patient 
to keep the ICD active(14). This could be due to a knowledge deficit in the relatives as well, and could 
be reduced by including them in ACP conversations(14). The concern of family conflicts was not 
mentioned in our focus group discussions, although one patient mentioned to keep the ICD on if her 
family would want so. 
There was debate on the timing of discussing ICD deactivation. Some patients were hesitant 
to discuss deactivation before implantation, although this would make it easier to start conversations 





about ICD deactivation often only occurred when indicated during follow-up or at the end-of-life(11, 
20). Postponing the discussion until the end-of-life is not recommended, since patients might have too 
little time to reflect upon their decision, and the last phase of life is hard to identify in heart failure 
patients(21), as shown in a previous study, in which only 15.7% of included healthcare professionals 
were confident in predicting death, which might impair the timing of ACP conversations(22).  
Previous research showed that ICD patients are more reserved than other patient groups 
towards ACP conversations, amongst others because the ICD is often implanted before patients 
perceive themselves as being seriously ill(13). Also, the ICD is often advocated as a solely life-saving 
device(23). Also in our study, some patients developed a complex psychological relationship with their 
ICD, viewing it as a ‘trusted friend’ and an integral part of their body, which might make it difficult for 
patients to talk or even think about deactivating the ICD(13, 24). In our study, some patients indicated 
they do not want a conversation about ICD deactivation. Although this should be respected to some 
extent, since ACP conversations should be tailored to the readiness and the phase of life of the 
patients(9), we do feel that the healthcare professional also has an informative role, in which all 
benefits, harms, and future perspectives of a treatment should be discussed. Also, patients should 
have the opportunity to elicit general treatment preferences and goals of care in addition to their 
deactivation preferences, since these might play a role in their later decisions about ICD 
deactivation(25). 
Possibly helpful for patients might be to record their wishes and preferences in an advance 
care directive. In our study, only few patients did so. This was also apparent in other studies that 
showed that patients do often have preferences recorded on for instance feeding tubes or respirators, 
but are hesitant to report preferences on ICD deactivation(26, 27). Possible explanations for this might 
be that preferences are subject to change, and patients are not certain whether their current wishes 
would represent their wishes at the end-of-life. However, recording preferences might help patients 
to actively think about their preferences, and could reduce ethical dilemmas or moral distress in 
relatives or healthcare professionals(28). Also, if patients are informed that the advance care directive 
is a ‘living’ document, which can always be adjusted, they might be less hesitant to record their wishes. 
This is one of the few studies exploring the experiences of ICD patients with ACP conversations 
in depth. A strength is its large number of participants(29) recruited in multiple centers. Yet, some 
limitations have to be addressed. Participants were recruited via the Dutch ICD patient association. It 
is possible that only people responded with special interest in the topic or with negative experiences, 
and that ACP conversations occur more often in practice. Also, it should be noted that most patients 
in the focus groups were in general good health, and not at the end of their lives, which might 





ample attention in the public and medical-professional domain to support ACP. More generally 
speaking, it is a country with a rather open debate about end-of-life decision-making, also showing 
from the issue of euthanasia that was mentioned in one of the focus groups. This means that our 
findings need replication in other countries and cultures. 
 
Implications 
This study and previous studies showed a variability in how and when patients want to be informed 
and in their attitudes towards deactivation. In line with the international ACP consensus statement(9), 
we recommend healthcare professionals to explore the patient’s readiness to talk about end-of-life 
and ICD deactivation, so that information can be tailored to the needs of the patient. Specific time 
points to explore this are before implantation, at battery replacement, when health deteriorates, or 
when a patient is referred to palliative care(1). Such conversations about ICD deactivation could be 
incorporated in more general conversations about goals of care, values, and preferences, so that a 
clear understanding of the patient’s wishes could be established. We recommend to involve relatives 




Many patients reflected on the role of their ICD at the end-of-life and report a need to be better 
informed about this topic. However, ACP conversations with the healthcare professional about 
treatment preferences and ICD deactivation seemed to be uncommon. Preferences about ICD 
deactivation were personal and dependent on the situation. Therefore, caution is advised in using 
one-size-fits-all approaches in informing the patient about deactivation. Some patients were hesitant 
to record their preferences in an advance care directive, since they were unsure whether their current 
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The implantable cardioverter defibrillator (ICD) is effective in terminating life-threatening 
arrhythmias. However, in the last phase of life, ICD shocks may no longer be appropriate. Guidelines 
recommend timely discussion with the patient regarding deactivation of the shock function of the ICD. 
However, research shows that such conversations are scarce, and some patients experience avoidable 
and distressful shocks in the final days of life. Barriers such as physicians’ lack of time, difficulties in 
finding the right time to discuss ICD deactivation, patients’ reluctance to discuss the topic, and the 
fragmentation of care, which obscures responsibilities, prevent healthcare professionals from 
discussing this topic with the patient. In this point-of-view article, we argue that healthcare 
professionals who are involved in the care for ICD patients should be better educated on how to 
communicate with patients about ICD deactivation and the end of life. Optimal communication is 
needed to reduce the number of patients experiencing inappropriate and painful shocks in the 





The implantable cardioverter defibrillator at the end of life 
The implantable cardioverter defibrillator (ICD) is highly effective in terminating potential life-
threatening arrhythmias. However, for patients at the end of life, the goal of the ICD – prolonging 
survival – may no longer be appropriate. Guidelines recommend early and regular discussion of the 
appropriateness of the ICD shock function throughout the disease trajectory and subsequently 
deactivation of the ICD at the end of life[1, 2]. The Dutch Association of Cardiology (NVVC) released a 
guideline in 2013[3] discussing the implications of the ICD at the end of life as well as the indication 
for and consequences of deactivating the device, but above all stresses the importance of discussing 
deactivation. Such discussions could be initiated before implantation (supported by a written patient 
folder), at follow-up (e.g. changing health, ICD battery change), and when entering the palliative and 
terminal phase. A recent Dutch study showed that only 35% of deceased ICD patients had discussed 
ICD deactivation. Further, 42% of patients had their ICD deactivated, and 9% experienced shocks in 
their last month of life[4], which have been reported as distressing for both patients and relatives[5]. 
In this point-of-view article, we discuss the barriers experienced by Dutch healthcare professionals to 
discussing ICD deactivation and provide future perspectives on clinical practice. 
 
Difficulties in discussing ICD deactivation 
It is important that discussions on ICD deactivation are conducted before the actual deactivation[4]. 
However, healthcare professionals struggle with such discussions, while many patients indicate that 
they want to be informed about this topic[6]. Some research has described the potential barriers 
healthcare professionals experience to discussing ICD deactivation[7-9]. These include having too little 
experience or knowledge with regard to talking about deactivation[10-16], not feeling comfortable 
discussing the topic[14, 17-20], a predominant focus on cure and on the benefits of ICD therapy[10, 
12, 18, 21, 22], having too little time to hold this conversation[12, 18, 19, 21], uncertainty about 
predicting patients’ disease trajectory[10, 12, 13, 21], being afraid of taking away hope[10, 12, 13, 19, 
21], not knowing at what stage this conversation is appropriate[10], not knowing who is responsible 
for these conversations[10, 15], a lack of multidisciplinary cooperation[18], and a stressful work 
environment and high workload[23]. However, almost all of these studies were conducted in the USA, 
and no research has yet been performed in the Netherlands. Given the open culture in the 
Netherlands with regard to end-of-life decision-making[24], it is remarkable to see that ICD 
deactivation discussions do not occur often. 
 
Barriers hindering Dutch healthcare professionals from discussing ICD deactivation 
We examined the experiences of Dutch healthcare professionals with ICD deactivation discussions in 





an academic and non-academic hospital and subsequently by using a snowball approach. Participants 
had to have experience in care for ICD patients at the end of life. Eighteen healthcare professionals 
participated in individual interviews, and two focus group meetings were held with four participants 
each. Interviews and focus groups were conducted between October 2017 and January 2018 using a 
predefined semi-structured topic list. Focus groups were led by experienced moderators (A.v.d.H. and 
J.A.C.R.), and the interviews were conducted by a psychologist (R.S.). Data were analysed using the 
constant comparative method. The characteristics of the participating healthcare professionals can be 
found in Tab. 1. 
 
Table 1. Characteristics of participating healthcare professionals (n = 26) 
Male gender 14 (54%) 
Age (mean, SD) 47.0 (11.3) 
Years of experience (mean, SD) 14.1 (8.5) 
Profession  
- Physiciana 11 (42%) 
- Nurseb 11 (42%) 
- ICD technician 4 (15%) 
Work place  
- Non-academic hospital 12 (46%) 
- Academic hospital 8 (31%) 
- Hospice 3 (12%) 
- General practitioner office 2 (8%) 
- Care home 1 (4%) 
ICD Implantable cardioverter defibrillator 
a4 cardiologists, 4 elderly care physicians, 2 general practitioners, 1 oncologist 
b5 cardiology nurses, 4 nurse specialists, 2 ICD nurses 
 
All healthcare professionals reported to experience some barriers to discussing ICD 
deactivation. Perceived barriers were related to clinical practice, the patient, or societal factors (Tab. 
2). A frequently reported barrier relating to clinical practice was experiencing a lack of time to discuss 
this topic. A nurse specialist in palliative care observed: ‘It calls for a different planning of consultation 
hours, because those conversations take more time, and the consultation hours are not really 
designed for that’. Other healthcare professionals described having a lack of knowledge about the ICD 
and the end of life, such as two elderly care physicians, who indicated that they were ‘unconsciously 
incompetent.’ A cardiologist pointed out that it is difficult to find the right moment to discuss ICD 
deactivation, and that it might be inappropriate to discuss this topic during routine appointments. 
However, the pre-implantation conversation held with all patients was also regarded as inappropriate 
by some, who stated that this conversation should focus on practical aspects of the ICD. Another 
barrier reported was the fragmentation of healthcare and the predominant focus of healthcare 





A nurse specialist remarked: ‘The cardiologist only looks at the heart, the pulmonologist only looks at 
the lungs… everybody is looking at his own small piece… we need to look at the patient as a whole. 
And that is sometimes not done’ . Other barriers related to clinical practice were concerns about taking 
away patients’ hope, difficulties in predicting the disease trajectory, a lack of experience in conducting 
such conversations, a lack of (awareness of) guidelines (only nine healthcare professionals mentioned 
the guideline of the NVVC), protocols which focus only on medical issues, and frequent staff turnover. 
 Healthcare professionals also experienced barriers related to the patient: they felt that 
patients are reluctant to discuss ICD deactivation and the end of life. Some argued that patients tend 
to overestimate the life-saving ability of the ICD and think that, if the ICD is deactivated, they will 
immediately die. Also, many patients do not seem to think the topic is relevant yet. At the start of the 
treatment, patients are focussed on living and the practical implications of the ICD. Later on in the 
disease trajectory, however, many patients are still not thinking about the end of life. A cardiologist 
compared this with retirement income: ‘There are certain things, and the same goes for retirement 
income, we know it is important, but did you ever delve into how much you will actually receive?… It is 
very difficult to motivate yourself to think about that in depth’. 
 Attitudes in society towards death and dying were also mentioned as barriers to discussing 
ICD deactivation. Several clinicians indicated that medicine and society are predominantly focussed 
on treating and curing illness, and length of life is often viewed as being more important than quality 
of life. An oncologist described: ‘Death should be a much more integral topic during life. We all want 
to be young forever, have no wrinkles, and whatever… We want to overcome everything, overcome 
cancer, cancer out of the world… it is nonsense… We get cancer. It is part of our lives’. A nurse specialist 
in palliative care said: ‘We can do everything, but not everything we can do is always appropriate. 
When you are 92, do you have to have a new aortic valve or a new ICD? And another, and another? 
How realistic is that?’. It was pointed out that no one can live forever, and that we need a different 
approach towards death and dying. 
 
Table 2. Barriers for healthcare professionals towards discussing deactivation of the implantable 
cardioverter defibrillator 
Clinical practice 
Lack of time 
Lack of knowledge about ICD in last phase of life 
Difficulty finding the right moment to discuss deactivation 
Lack of communication/coordination between healthcare professionals 
Little insight into what other healthcare professionals do 
Focus on practical matters 
Focus on own discipline (fragmentation) 
Being afraid to take away patients’ hope 





Difficulty predicting patients’ disease trajectory 
Feeling uncomfortable discussing last phase of life 
Lack of experience discussing last phase of life 
Focus on life-saving potential of ICD 
Too little education on last phase of life, palliative care, and communication 
Lack of (awareness of) guidelines 
Uncertainty about who is responsible 
Poor relationship with the patient 
Lack of facility for a calm conversation 
Difficulty stopping treatments 
Protocols focus on medical aspects 
Too much staff turnover 
Patients 
Reluctance to discuss/think about topic 
Last phase of life not yet relevant/focused on practical matters 
Overestimating life-saving character of ICD 
Lack of knowledge about deactivation 
Young age of patient 
Topic too emotional 
Culture/religion 
Association with euthanasia 
Lack of knowledge about what is medically possible 
Society 
Medicine/society focused too much on treatment/cure 
  
Future perspectives 
Despite guidelines on how to adequately address deactivation of the ICD shock function at the end of 
life, many patients never discuss ICD deactivation and die with an active ICD, some after experiencing 
painful shocks[4-6]. Palliative care, the end of life and advance care planning[25] are atypical subjects 
in the highly technological field of cardiology, but are of great importance[26]. However, healthcare 
professionals experience barriers to discussing these topics. Action is needed to increase attention to 
these topics and to overcome barriers. Educating healthcare professionals about the importance of 
discussing ICD deactivation and the last phase of life is needed, and can increase their involvement in 
advance care planning[27, 28]. 
A recent UK study by Javaid and colleagues reported on an easy-to-implement but effective 
programme to improve the attention given to ICD deactivation[29]. This programme encompassed: 
(1) raising awareness and increasing knowledge about ICD deactivation by presenting research and 
guidelines to different medical departments; (2) e-mailing all staff who were not able to be present 
during these presentations; (3) developing and distributing informative posters about the ICD and end-
of-life care on medical wards; and (4) offering teaching and checklists to staff working on medical 
wards. After implementation of this programme, ICD deactivation increased from 0 to 54% and none 





study was small, the results are promising. Healthcare professionals in the Netherlands taking care of 
ICD patients should critically review how care at the end of these patients’ lives is organised. To further 
facilitate and initiate advance care planning discussions, consultation schedules and the role of nurses 
might be revisited, since they might be well suited to initiate discussions with patients regarding the 
future role of their ICD[18, 21, 30]. Advance care planning and discussions about end-of-life care 
should become an integral part of cardiological care. Only then can we reduce the number of patients 
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The overall aim of this thesis was to provide insight into self-management behaviours and advance 
care planning (ACP) practices of patients living with an advanced illness, by studying patients with 
advanced cancer and patients with an implantable cardioverter defibrillator (ICD). In this general 
discussion, the main findings of this thesis are described and interpreted, methodological 





In part I of this thesis, self-management was examined in a population of patients with advanced 
cancer. The aim was to better understand the consequences of having advanced cancer and patients’ 
self-management to deal with these consequences. Further, the aim was to examine healthcare 
professionals’ experiences and attitudes towards patients’ self-management, and their perceived 
roles in self-management support. Self-management was defined in our studies as “the strategies used 
by persons with the aim of managing the physical, psychosocial and existential consequences of living 
with a progressive, life-threatening disease and its treatment”(1). 
 
Research question 1: How do patients with advanced cancer deal with the consequences of their 
illness and its treatment? 
Patients with advanced cancer who participated in interviews about self-management described a 
large number of consequences of living with advanced cancer and its treatment in multiple domains, 
such as the physical domain, the psychological domain, the social domain, the existential domain, the 
medical domain, and the domain of daily life. In our systematic review of the international literature 
and in our interview study with patients with advanced cancer, a large number of self-management 
behaviours were identified (Table 1). As a whole, these self-management behaviours can be 
synthesized into six categories: health behaviours; psychological strategies; behaviours related to 
seeking and providing social support; behaviours related to collaborating with healthcare 
professionals; behaviours related to obtaining knowledge and information; and behaviours related to 
planning. Self-management behaviours were often used in multiple domains. For instance, planning 
was used to organize medical appointments, but also to organize household activities. Also, self-
management behaviours were used complimentary in the same domain. For instance, in order to deal 
with sadness, patients used health behaviours, such as staying physically active, but also psychological 
strategies, such as keeping a diary. Patients generally tried to live as normally as possible. However, 





instance, much time on adhering to sometimes complex medication schemes and coordinating their 
medical appointments. 
 
Table 1. Self-management behaviours of patients with advanced cancer 
Category of behaviour Self-management behaviours 
Health behaviours • Dieting 
• Monitoring symptoms 
• Relaxation 
• Self-administering and adjusting medication 
• Staying physically active 
• Using complementary and alternative treatments 
Psychological strategies • Accepting, ignoring or downplaying illness 
• Keeping a diary 
• Practicing religion 
• Seeking distraction 
• Using mindful self-help strategies 
Behaviours related to seeking 
an providing social support 
• Limiting social interactions 
• Providing social support to others 
• Seeking support from family, friends or others 
• Volunteering in patient associations 
Behaviours related to 
collaborating with healthcare 
professionals 
• Engaging in ACP 
• Investing in relationship with healthcare professional 
• Making decisions about treatment 
• Seeking support from healthcare professionals 
Behaviours related to obtaining 
knowledge and information 
• Avoiding or neglecting information 
• Coordinating information dissemination to relatives 
• Seeking information about illness, treatment and self-
care on the internet 
Behaviours related to planning • Adhering to medication schemes 
• Coordinating medical services 
• Dividing and planning activities over the day 
• Maintaining normal daily routine 
• Making financial and practical plans 
• Planning moments of rest 
• Short-term goal setting 
 
Research question 2: What factors influence self-management of patients with advanced cancer? 
In our review of the international literature on self-management, different factors that might influence 
self-management of patients were identified, such as age: younger patients performed more 
physically and socially active self-management behaviours; educational level: higher educated 
patients were more proactive and reported a higher self-perceived effectiveness of their self-
management; and self-efficacy: patients with higher levels of self-efficacy perceived their symptoms 
more often as modifiable. The studies in our review were however non-experimental studies, with 





to which the results should be interpreted with caution. In our qualitative interview study, we found 
no evidence that age, gender or educational level affected patients’ self-management. Rather, we 
found that self-management is influenced by patients’ personality, their life history, the moment in 
the illness trajectory and the involvement of their social environment. Most patients indicated not to 
be aware of why they dealt with consequences in certain ways, and indicated they ‘always did things 
like this’. This suggests that patients often draw from their usual self-management behaviours, and 
try to apply and adjust these to their new situation of dealing with advanced cancer. 
 
Research question 3: What are the experiences and attitudes of healthcare professionals towards 
self-management of patients with advanced cancer, and what self-management support roles can 
be distinguished? 
Healthcare professionals who participated in our interview study experienced patients’ self-
management as highly individual and diverse. Most healthcare professionals where optimistic about 
patients’ self-management abilities and behaviours, although some mentioned concerns about the 
patients who seemed less able to engage in self-management. Healthcare professionals adopted 
different roles in supporting patients’ self-management. These were: the instructive role, in which the 
healthcare professional is leading, and directs patients’ self-management based on their own 
professional expertise; the collaborative role, in which a well-delineated division of tasks between 
patient and professional is apparent and both patient and healthcare professional directed strategies 
are integrated; and the advisory role, in which the patient is leading, and a more patient-directive 
strategy is apparent, in which the healthcare professional is more ‘serving’ the patient. The role of the 
healthcare professional was dependent on their working conditions and clinical experience, their 
personality and life experience. Some healthcare professionals preferred or inclined towards one of 




In part II of this thesis, advance care planning (ACP), an expression of self-management which is very 
relevant for patients with advanced illness, was examined. ACP is commonly defined as “enabling 
individuals to define goals and preferences for future medical treatment and care, to discuss these 
goals and preferences with family and health-care providers, and to record and review these 
preferences if appropriate”(2). ACP was examined in a population of patients with an ICD. The aim of 





of patients, relatives, and healthcare professionals with ACP conversations about whether or not to 
deactivate the shock function of the ICD. 
 
Research question 4: What is the impact of having an active ICD in the last phase of life? 
In our review of the international literature, up to 33% of patients who died due to non-sudden causes 
experienced shocks from their ICD on the last day of life, and up to 14% in the last hour of life. Up to 
68% of the patients who died due to sudden causes experienced shocks on the last day of life and up 
to 66% in the last hour of life. Studies that did not differentiate by cause of death showed that up to 
32% of patients experienced shocks in the last month of life, up to 32% on the last day of life and up 
to 31% in the last hour of life. In the medical record study in which we examined the records of 380 
deceased ICD patients, 70% of patients died with an active ICD. In 7% of these patients, their medical 
record included reports about shocks in the last month of life. However, since most patients had died 
outside the hospital, we assumed that the shock incidence might be higher, and reports of bereaved 
relatives might possibly be more accurate. This was examined in our mixed-methods study in which 
170 relatives of 154 deceased ICD patients participated. They reported that of all patients, 24% had 
experienced a shock in the last month, and 10% on the last day of life. Experiencing shocks in the last 
phase of life had a negative impact on both patients and relatives. Shocks were distressing for 74% of 
patients and 73% of relatives. Most often reported sources of distress were pain and fear in patients, 
and fear and worry in relatives. 
 
Research question 5: How and when are decisions about ICD deactivation made, and what factors 
influence these decisions? 
ICD deactivation was discussed with 35% of patients who had died between 2013 and 2016, based on 
the notes in the medical records of these patients. This was comparable to what bereaved relatives 
reported in our mixed-methods study: 38% of patients discussed ICD deactivation with their 
healthcare professional. These discussions occurred late in the illness trajectory, often in the last week 
of life. Only 11% of patients had discussed deactivation during the pre-implantation conversation. In 
the medical record study and in the mixed-method study among relatives of deceased ICD patients, it 
was found that between 30% and 55% of ICD patients had their ICD deactivated before death. The ICD 
was deactivated late in the illness trajectory, most often in the last days of patients’ lives. Patients 
who had had a conversation about ICD deactivation were 69 times more likely to have their ICD 
deactivated compared to patients who did not have this conversation. Other factors that positively 
influenced the decision to deactivate the ICD were having a do-not-resuscitate or do-not-intubate 






Research question 6: What barriers do patients and relatives experience towards ACP conversations 
about ICD deactivation? 
Many ICD patients in the focus groups indicated to be interested in having ACP conversations about 
ICD deactivation with their healthcare professional, although few patients had had this conversation. 
Patients described that their healthcare professionals were knowledgeable about many medical 
issues, but some patients indicated there was not always the opportunity to discuss topics with a 
strong emotional component, such as the end of life. Preferences about the timing of these 
conversations were varied: some wanted this conversation during the pre-implantation phase, others 
would want this when ICD deactivation becomes more directly relevant. In our focus groups with 
relatives of deceased ICD patients, numerous barriers towards having ACP conversations about ICD 
deactivation were identified. Some of the barriers were related to the patient and relatives, such as a 
lack of willingness to discuss ICD deactivation, thinking the topic is not relevant yet, having a lack of 
knowledge about the functioning of the ICD and having a disturbed relationship with the healthcare 
professional. Other barriers were related to the healthcare professional and the healthcare system, 
such as a perceived lack of knowledge of the healthcare professional about the functioning of the ICD, 
a perceived lack of time of the healthcare professional to engage in ACP conversations, and a lack of 
patient-centeredness.  
 
Research question 7: What barriers do healthcare professionals experience towards ACP 
conversations about ICD deactivation? 
Healthcare professionals who were interviewed and participated in focus groups about ICD 
deactivation experienced several barriers towards having ACP conversations about ICD deactivation 
with their patients. Barriers were experienced on three levels: their clinical practice, the patient and 
society. Most often reported barriers on the clinical practice level were having a lack of time and 
knowledge about the ICD and the last phase of life, and having difficulties finding the right time to 
start an ACP conversation. On the patient level, healthcare professionals sometimes experienced 
reluctance of the patient towards discussing the topic, or thought the last phase of life was not yet 
relevant to discuss. On the societal level, healthcare professionals indicated that medicine in general 
and society is too much focused on curing patients. They also noticed that healthcare professionals 
were often mainly focused on their own discipline, which could lead to fragmentation of care and 









A variety of methodologies were used to examine the research questions outlined in the introduction. 
Chapter 2 and 5 both described literature reviews (of which one systematic and one integrative). 
Chapter 3, 4, 7 and 9 described studies with a qualitative design (of which three individual interview 
studies and one focus group study). Chapter 6 described a medical record study. Chapter 8 described 
a mixed-methods study, including a survey and a qualitative focus group study. These methodologies 
will be briefly discussed in this section. The variety of research methods used is a strength of the 
studies in this thesis. Self-management and ACP were first examined by summarizing all existing 
literature in two reviews, and subsequently by using quantitative and qualitative research methods. 
The quantitative studies provided us with clear numbers, while the qualitative studies provided us 
with a detailed and in-depth understanding of the studied concepts(3-5). Especially with issues that 
are difficult to describe or understand in numbers, and largely depend on the subjective experiences 
and attitudes of those involved, such as self-management and ACP, qualitative methods are ideally 
suited to investigate this(6). This meticulous approach expands our knowledge and provided us with 
a deep understanding of self-management and ACP in the two specific populations. 
 
Reviews 
A potential limitation of the reviews in chapter 2 and chapter 5 is that some studies might have been 
missed, for instance because they were not indexed in the scientific databases that were searched, 
because certain keywords were missed, or because studies were published in languages other than 
English. In chapter 2, we used a broad definition and a variety of search terms for ‘self-management’, 
but it is possible that we missed research that used different terms for the same concept. In this 
review, the included studies were often of moderate quality. Studies were especially affected by 
selection bias. Little information was provided on inclusion and exclusion criteria and response rates. 
It is possible that the included studies largely involved patients who were more than the average 
patient able and willing to engage in self-management, thereby impairing the generalizability to a 
larger population. In the review on ICD shock incidence in chapter 5, the included studies had relatively 
small study populations and were relatively old, often conducted more than 20 years ago. In recent 
years, we have seen large improvements in ICD technology, such as antitachycardia pacing (ATP), 
longer detection times and high rate cut-offs(7, 8). Also, ICDs are currently more often implanted in 
patients for primary prevention instead of secondary prevention, and these patients have a lower risk 









In chapter 3, 4, 7, 8 and 9, qualitative research methods such as interviews and focus groups were 
used. Such methods rely on the subjective experience of the participants, and caution is advised in 
generalising the results to a larger population(3, 4, 12). Participation bias should be considered, for 
instance in chapter 3, 7 and 8 in which participants were recruited via calls for participation in 
magazines, websites and social media channels. This might mean that only people enrolled with a 
special interest in the topic or with negative experiences. Recall bias should also be considered, for 
instance for the interview study reported on in chapter 8, in which relatives of deceased patients 
participated. It might be possible that participants were not always able to remember important 
information. Generally, the longer the time between the death of the patient and the timing of the 
interview, the more information is lost(13). However, past experiences that are significant to the 
respondent or have a long duration are usually less prone to recall bias(14). The death of a loved is 
such an experience, and therefore, recall bias may be minimal in our studies that rely on the relatives’ 
memory, such as in chapter 8. 
 
Medical record studies 
In chapter 6, the results of a retrospective study of medical records were described. In this study, 
medical records of patients who had their ICD implanted from 1999 onwards were examined. 
Although this is an effective method to examine ICD deactivation and ICD shocks, some limitations 
have to be considered. Many medical records consisted of a large amount of scanned, handwritten 
notes from healthcare professionals, which were sometimes hard to read and poorly organized. Also, 
it might have been possible that medical records were incomplete, which could also have led to an 
underreporting of the studied variables(15). Although the data was meticulously collected, it is 
possible that some information was missed, especially concerning the occurrence and exact content 
of ICD deactivation discussions with the patient. This could mean that in reality, ICD deactivation 
discussions, ICD deactivation, and shocks occurred more often than we could demonstrate. Also, in 
the patient sample in chapter 6, more than half of the patients died outside the hospital, and the last 
days of life were not always recorded in the medical record. We therefore sometimes missed data 
from the last months of life of these patients. This was partly accounted for by contacting the GP of 





records in only two hospitals were examined. In order to gain a broader insight in the studied variables, 
replication is necessary in other hospitals in the Netherlands and beyond. 
 
Survey 
In chapter 8, the results a mixed-methods study were reported, in which relatives completed a survey. 
Relatives were recruited via the hospital medical records of deceased patients. However, a large 
number of telephone numbers were no longer used or were incorrect. Nonetheless, we had a 
reasonable response rate in this study (59%), thereby reaching a large group of relatives. Relatives 
most often were the spouse of the deceased patient and were closely involved in the last phase of life 
of the patient, thereby providing us with first-hand information. However, recall bias should also be 
considered. It might be possible that relatives were unable to recall certain events that found place in 
the last months of life of their loved ones. 
 
INTERPRETATION AND INTEGRATION OF THE FINDINGS 
 
Living with a progressive, life-threatening illness 
 
The vast and hard work of being ill 
Having a progressive, life-threatening illness, such as cancer or cardiovascular disease, greatly disrupts 
patients’ lives. In the interview study presented in chapter 3, patients described experiencing 
numerous consequences of having advanced cancer and its treatment on many domains of life. They 
experienced consequences in the physical, psychological, social and existential domain, but also in the 
medical care domain and in their daily living activities. Previous research, as summarized in the 
systematic review described in chapter 2, showed similar consequences. Patients engage in numerous 
activities to deal with the consequences of their advanced illness. These activities are diverse and 
individually determined, and are influenced by the patients’ personality, their life history, the phase 
of illness and the involvement of the social environment. Other studies that used quantitative research 
methods also showed that age, level of physical functioning, income, education, self-efficacy and 
symptoms of anxiety and depression influence the patient’s self-management(16-19). Mostly, 
patients in our studies indicated to be able to effectively deal with their illness and its consequences. 
However, some patients indicated to sometimes struggle with self-management, which was also 
confirmed by some of the healthcare professionals who participated in our interview study about self-
management (chapter 4). These patients experienced a high treatment burden. Treatment burden 





to treatment regimens, and to self-manage their symptoms, next to the demands of everyday life(20). 
A high treatment burden leads to the patient feeling overwhelmed, noncompliance to treatment, 
poorer health outcomes, and an impaired quality of life(20-23). 
Living life as normally as possible, for instance by continuing to practice hobbies or usual daily 
living activities, was frequently mentioned as important in the interviews by patients with advanced 
cancer. Some patients had difficulties with this. These patients indicated that their illness and its 
treatment largely dictated their agenda, and said they were sometimes approached differently by 
others. The patients with an ICD who participated in our focus groups had similar experiences, and 
indicated the need to live their lives as normally as possible. Other research also showed that patients 
want to continue living their normal life with reasonable independence, and do not always want to be 
approached as a patient(24). However, for some patients, living a normal life is threatened by the 
medical work they have to perform. As Corbin and Strauss postulated, and as was described in chapter 
1, managing an illness requires ‘medical work, daily life work, and biographical work’(25). When 
patients’ lives are overwhelmed with medical work, patients are hampered in living their usual daily 
lives. Concluding, having a progressive, life-threatening illness is hard work which potentially 
threatens patients from living their normal lives(1, 26). Patients should be supported and empowered 
in making sure they are able to deal with the consequences of their illness(27). 
 
Living in the ‘here and now’ versus preparing for the future 
As described in the general introduction in chapter 1, ACP can be considered an expression of self-
management. ACP consists of three key elements: 1) reflection on wishes and preferences for future 
medical treatment and care; 2) discussing these with healthcare professionals and relatives; and 3) 
recording and, if necessary, reviewing these. In other words, ACP can help patients to prepare for 
future healthcare decision-making. But are patients willing to engage in ACP? In our systematic review 
and interview study on patients with advanced cancer (chapter 2 and 3) and our interview study with 
patients with an ICD (chapter 7), we saw a variety in the needs and willingness to engage in ACP. Some 
patients were actively thinking about the end of life and future healthcare preferences, and were 
interested in discussing these with healthcare professionals, although ACP conversations did not occur 
often (chapter 5 to 9). Other patients were more reserved towards thinking about future treatment 
and care and the end of life. They were focussed on living in the ‘here and now’, and not on preparing 
for the end of life. Other studies also found that patients with a progressive illness are sometimes 
ambivalent towards discussing the end of life and ACP(28, 29). Moreover, they sometimes seem to 
fluctuate between actively thinking about their illness and future deterioration on the one hand, and 





could hamper actual ACP conversations, since it can make healthcare professionals uncertain about 
when to start this conversation(31). An important element of ACP is to explore the needs and 
readiness of patients to engage in ACP(2). Research showed that ACP is only beneficial when patients 
are ready to engage in this(32). However, there is also evidence that, even if patients do not seem 
ready to have this conversation, they in hindsight agree that the conversation was beneficial(32). This 
means that healthcare professionals should not be hesitant to broach this topic when patients do not 
seem to be fully ready to engage in ACP, especially since the ACP process itself could promote patients’ 
readiness to engage in ACP(29). The fact that patients are ambivalent towards having this conversation 
should not mean that this conversation should not occur. Actually, the fact that something is difficult 
or uncertain should be a trigger for exploration instead of avoidance(33). 
 
Working together to promote self-management and ACP 
 
How does the healthcare professional appreciate patients’ self-management? 
The healthcare professionals we interviewed about self-management (chapter 4) were generally 
positive about their patients’ self-management, but also worried about the patients who seemed less 
able to adequately deal with the consequences of their illness. They indicated that some patients are 
unwilling or not able to deal with their impaired health, and that some patients may be disadvantaged 
by the shift away from traditional, paternalistic medicine towards a model in which patients are more 
in charge of their health. Some healthcare professionals indicated that patients struggle with the 
medical management of their illness. A nurse who was interviewed for instance described how a highly 
educated man was given the flexibility to determine the amount of pain medication he needed. 
However, this patient struggled with doing so, since he was not able to decide what to do. It has been 
shown before that the medical management of an illness is something patients may struggle with, 
especially when their condition deteriorates, or when they become more bedbound towards the end 
of life(1, 24, 34). In a large study among 2078 Dutch healthcare professionals, patients and 
policymakers, it was also found that healthcare professionals are sometimes sceptical about self-
management(35). This study showed that 42% of participants doubted whether all patients are 
capable of self-management, and another 22% doubted whether patients want to take up this 
responsibility(35). In our interview study among healthcare professionals about self-management 
(chapter 4) and in previous research(36, 37), we saw variations in patients’ self-management and self-
management support needs. Patients often describe a significant need for support in self-
management of the physical consequences of their illness, such as managing symptoms and 





managing the psychosocial consequences of their illness and treatment(24, 37, 39). These self-
management support needs should be frequently revisited throughout the illness trajectory. 
 
The importance of the patient – healthcare professional relationship 
The participants in our studies indicated that having a good relationship with the healthcare 
professional is essential, for instance when having ACP conversations, making treatment decisions, or 
when talking about delicate issues such as the end of life. Healthcare professionals were also aware 
of the importance of a good patient-healthcare professional relationship (chapter 4 and 9). In our 
interviews with patients with advanced cancer (chapter 3), we found that the patient’s personality 
and life history are important factors influencing one’s self-management. In order to obtain a clear 
picture of patients’ self-management and self-management needs, it is thus important for a 
healthcare professional to look ‘behind’ the illness, and to approach the patient as a whole. This can 
only be accomplished when having a good relationship based on trust, which is something that should 
be invested in(40). 
 In the interview study in which healthcare professionals were interviewed about self-
management (chapter 4), three roles of self-management support were identified: an instructive role, 
in which healthcare professionals try to direct and stay in charge of patients’ self-management; a 
collaborative role, in which the professionals and patients work together, but in which the healthcare 
professional also expects patients to rely on their medical expertise; and an advisory role, in which the 
patients are more in charge and the healthcare professionals have a more ‘serving’ role. Similar roles 
were described by Van Hooft in 2015, who specifically looked at the roles of nurses(41). It is important 
to note that none of the roles is always ‘the best’ option. Different patients have different needs, 
which may also change over time. Most important is looking for a division of tasks that best suits the 
patient. Most healthcare professionals who participated in the focus groups about self-management 
were able to do so, and indicated to switch between roles if necessary. However, healthcare 
professionals sometimes experience difficulties towards supporting self-management and having ACP 
conversations (chapter 4 and 9). Especially concerning ACP, some healthcare professionals experience 
barriers. Healthcare professionals can be hesitant to talk about difficult topics such as the end of life, 
especially in medical specialties that are mainly focused on curing illness rather than on providing 
comfort care(33, 42, 43). 
Patients and healthcare professionals have to work together. Creating a mutual participating 
relationship enhances patients’ adherence to treatment regiments, improves health outcomes and 
increases patients’ satisfaction with healthcare(44-46). Further, it reduces hospitalizations and stress 





where patients and healthcare professionals often have a long-term treatment relationship, they are 
mutually interdependent: the healthcare professionals use their clinical and scientific expertise to 
treat and support their patients, while the patient’s own experiential knowledge could provide 
important clues for further treatment and can complement the knowledge of the healthcare 
professional(48, 49). Establishing a good relationship and integrating both the healthcare 
professionals’ and patients’ knowledge is vital in making treatment decisions that best suit the 
patients(49).  
 
Self-management, ACP, and COVID-19 
At the time of completing this thesis, the corona virus is spreading across the globe, resulting in a 
world-wide pandemic. The corona virus causes the infectious disease COVID-19. Around 80% of 
people recover from the illness, which causes fever, dry cough and tiredness, without needing hospital 
treatment. However, around 20% of people become seriously ill and develop a difficulty with 
breathing(50). Due to the strict measures taken, the impact of the pandemic on daily life is large. 
Measures such as closing down schools, restaurants, limiting non-essential medical visits, and social 
distancing prevent people from living their usual daily lives(51, 52). Self-management is important to 
adjust to this new situation, such as working from home, ordering groceries and staying in contact 
with friends or healthcare professionals via video calling. 
For frail people or those with progressive, life-threatening illness, the consequences of the 
pandemic are even greater. Early reports show that patients with comorbidities such as cardiovascular 
disease or cancer are at greater risk for developing advance respiratory disease and death, probably 
due to a less rigorous immune response(53). Also, patients with cancer have an increased risk of 
needing mechanical ventilation, being admitted to the intensive care unit, and death associated with 
COVID-19(54, 55). This has a large impact on the sometimes already complex self-management of 
patients’ progressive illness, for instance in staying in contact with healthcare professionals, 
maintaining treatment regimens, and making decisions about potentially postponing treatment(56). 
Early qualitative studies of patients with cancer show that they are worried about contracting the virus 
and developing severe complications(57). Further, social isolation is a problem for these patients. 
Patients with advanced cancer often already experience feelings of social isolation, and COVID-19 
further disrupts their social lives(58). Patients with progressive illness are more confined to their 
homes compared to the general population, and are recommended to only be exposed to their family, 
thereby limiting their social interaction(59), while especially for these patients, social interaction is 
often valued as being very important(22). Concerning ACP, there are discussions in the media and 





61). As a response, several guidelines are developed specifically aimed at ACP in patients with COVID-
19 or those that are more vulnerable to contract the virus(62, 63). Although social distancing and 
remote consultation makes ACP challenging, COVID-19 also creates opportunities. ACP conversations 
do not occur often, and the pandemic may provide a trigger to initiate these discussion(64). Whether 
these conversations are conducted face-to-face or via remote consultations, most important is that 
these are conducted in the first place(61). Several online decision aids were developed and are readily 
available(65, 66). 
The COVID-19 pandemic shows the importance, but also the complexity of self-management 
and ACP. Everybody is introduced to what it is like to rigorously manage their daily life, maintain 
normality as much as possible, and deal with the challenges involved. For all people, but especially for 
those living with progressive illness: self-management and ACP are essential, and should be promoted 
and supported. 
 
RECOMMENDATIONS FOR CLINICAL PRACTICE 
 
Self-management should be individually supported 
Self-management support for patients with advanced cancer should include an individualised 
approach that re-evaluates patients’ needs and wishes, which is embedded in solid partnerships with 
the relatives and healthcare professionals, and which is incorporated in existing models of care. An 
individualised approach is important, since patients show different needs in the support they want to 
receive. For instance, some patients indicated to struggle with different aspects of their medical 
management, such as planning appointments and adhering to treatment regiments (chapter 3), while 
other patients indicated a need for more psychosocial support (chapter 7). 
 
Frequent ‘self-management check-ups’ should be considered 
Frequent check-ups by healthcare professionals on how patients are managing their illness, in which 
ACP is incorporated as well, are appropriate. These check-ups could be conducted by a nurse from the 
main treating department. This was supported by a study in which 262 physicians and nurses 
participated. In this study, 81% of healthcare professionals thought that nurses have the necessary 
skills to conduct such conversations(67). The nurse could play a central, coordinating role in the illness 
trajectory of the patients and should frequently, in collaboration with the patients, review their self-
management, expectations, responsibilities, needs and preferences, and refer the patient to other 





psychologist(67-69). The array of tasks, responsibilities and the needs of the patient should be critically 
reviewed during these check-ups, rather than assuming the patient is able to self-manage(70). 
 
Teach patients general self-management skills 
Patients could benefit from receiving general education about self-management. Numerous self-
management support programmes have been described within the literature benefiting the 
patients(71, 72), for instance in terms of illness related knowledge(73), performance of self-
management behaviours(71, 74), and in decreasing symptoms such as fatigue(75) and pain(74), while 
increasing their self-reported quality of life(76). We recommend to provide patients with a program 
aimed at education and self-management early in the illness trajectory, integrated into routine 
practice(77-79). An example of such a program is the ‘PEP’-program which is used in cardiac 
rehabilitation. This program includes four sessions about different topics, such as dealing with stress, 
emotions, but also resuming household activities, work, and maintaining the relationship with 
significant others(80). During the illness trajectory, self-management support can be adjusted based 
on the specific needs of the patient on that point in time. 
 
Consider using eHealth in supporting patients’ self-management 
eHealth could play a valuable role in supporting self-management. The use of eHealth, such as apps, 
can be beneficial for patients receiving palliative care(81). One example is an app in which patients 
register their cancer-related pain, and can have direct contact with a nurse when the patient thinks 
this is appropriate(82). A meta-analysis showed that the use of eHealth interventions increases the 
illness-related knowledge of patients, their perceived support and healthcare participation(83). 
Another recent scoping review showed that web-based ACP programs are feasible and improve 
patients’ ACP knowledge, communication, and documentation(84). However, it should be considered 
that the use of technology does not only have benefits. Some patients, such as older patients or those 
who are more ill, might have difficulties in using eHealth, or might not have enough energy to for 
instance use a laptop or tablet(85, 86). Further, the use of eHealth should not be a substitution for 
face-to-face contacts and it should be considered that patients might not always have the necessary 
skills to use and interpret eHealth in light of their own situation(87). 
 
Healthcare professionals should be educated in self-management support and ACP 
Healthcare professionals differ in their approach towards supporting patients’ self-management, and 
sometimes struggle with supporting self-management and conducting ACP conversations with their 





might be most appropriate, we cannot expect all healthcare professionals to be able to switch 
between these approaches and be skilled in all of these. However, when healthcare professionals are 
aware of their own preferences and style, and clearly communicate these to their patients and 
colleagues, they might still be able to adequately support the patient. Therefore, not only education 
and training on practical self-management support is recommended, but also education to increase 
self-knowledge and critical self-reflection. Also, healthcare professionals should be educated about 
the importance of discussing the end of life and eliciting patients’ preferences about future treatment, 
starting in medical school, since this increases the healthcare professionals’ engagement in ACP(88, 
89). 
 
RECOMMENDATIONS FOR FUTURE RESEARCH 
 
For future research, we suggest to further examine what factors influence self-management of 
patients at the end of life, and the self-management support needs of patients with advanced cancer 
and ICDs. Also, a self-management support program specifically for patients with progressive illnesses 
should be developed and tested, in which ACP should also be incorporated. Specifically, it should be 
examined how such a program can be integrated in existing care. Having an eHealth component is 
recommended, amongst other due to its accessibility for patients. Currently, initiatives are ongoing to 
develop such a program(90). We further suggest to examine whether educational programs and 
practical decision aids for healthcare professionals, such as checklists or reminders in the medical 
record of the patient, could promote the occurrence of ACP conversations, especially in medical 
specialties where end-of-life care is less prevalent. Lastly, relatives might potentially play an important 
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Chapter 1 provides an introduction on this thesis about self-management and the practice of advance 
care planning (ACP) of patients with progressive, life-threatening illness. It elaborates on the shift from 
healthcare based on the biomedical model, in which the healthcare professional tended to make 
decisions about treatments in the best medical interest of the patient, but made these decisions 
unilaterally, often without consulting the patient, towards healthcare based on the biopsychosocial 
model, in which a larger emphasis is put on individual choice and autonomy of the patient, and in 
which shared decision making is an important component. In this model, a major role and 
responsibility is placed on the patient, while at the same time, the healthcare system is becoming 
more and more fragmented, specialised and complex. It is not known to what extent patients are 
willing and able to take an active role in their care. Self-management, in this context defined as “the 
strategies used by persons with the aim of managing the physical, psychosocial and existential 
consequences of living with a progressive, life-threatening disease and its treatment” gained increasing 
attention in research and in clinical practice, but has rarely been examined in patients with advanced 
illness. In addition, little is known about the practice of ACP in patients with advanced illness other 
than cancer. Therefore, the aim of this thesis was to provide insight into self-management behaviours 
and ACP practices of patients living with an advanced illness. Self-management was examined in a 
population of patients with advanced cancer, and ACP was examined in a population of patients with 
an implantable cardioverter defibrillator (ICD).  
 
Part I: Self-management of patients with advanced cancer 
Chapter 2 presents the results of a systematic review on the experiences and attitudes of self-
management of patients with advanced cancer. Seven databases were systematically searched and 
31 out of 1742 identified articles were included. These studies, of which 8 were quantitative and 23 
were qualitative, reported on a variety of self-management behaviours in seven domains: medicine 
and pharmacology, lifestyle, mental health, social support, knowledge and information, navigation 
and coordination and medical decision-making. We found that the behaviours patients used were 
individual and sometimes ambivalent. Influencing factors of self-management were age, mental state, 
physical function, education and self-efficacy: older patients, patients with depressive symptoms and 
those with lower levels of physical function, education and self-efficacy sometimes struggled with self-
management of their illness. Three studies indicated that healthcare professionals thought self-
management is desirable and achievable, given that it is based on sufficient skill, knowledge, and a 





highly personal and multifaceted. Self-management support can benefit from an individualised 
approach, embedded in solid partnerships with relatives and healthcare professionals. 
 
Chapter 3 includes the results of a qualitative interview study in 33 patients with advanced cancer. 
Patients indicated that their diagnose of advanced cancer had a major impact on different domains of 
their life, being physical, psychological, social, existential, medical, and daily life. Patients engaged in 
different self-management behaviours to deal with these consequences. These were divided in six 
categories: health behaviours, such as staying physically active and maintaining a healthy diet; 
behaviours to manage psychological consequences, such as nuancing thoughts or writing down 
thoughts in a notebook; behaviours related to seeking and providing social support; behaviours 
related to collaborating with healthcare professionals; behaviours related to obtaining knowledge and 
information; and behaviours related to planning, such as daily life and adhering to medication 
schemes. Patients indicated that living as normally as possible, despite their illness, was important. 
Different factors seemed to influence patients’ self-management, such as their personality, their life 
history, the moment in the illness trajectory and the involvement of their social environment. Most 
patients were however not always aware of why they dealt with the consequences of their illness in a 
certain way. They often indicated to ‘always have done things like this’. This suggests that patients try 
to draw from their already existing self-management behaviours in order to deal with their new 
situation of living with advanced cancer. 
 
Chapter 4 reports on a qualitative interview study amongst 27 healthcare professionals caring for 
patients with advanced cancer. We examined their experiences and attitudes towards self-
management of their patients, and their self-management support roles. Generally, healthcare 
professionals were optimistic about self-management of their patients, although some mentioned 
concerns about the patients who seemed less able to engage in self-management. Healthcare 
professionals adopted different roles in supporting self-management. These were: the instructive role, 
in which the healthcare professional adopts a leading role, and directs patient’s self-management 
based on their own expertise; the collaborative role, in which a well-delineated division of tasks 
between healthcare professional and patients is apparent; and the advisory role, in which the patient 
is leading, and the healthcare professional is more serving. Healthcare professionals seemed to 
attribute their role to patients’ characteristics, but also to their own working conditions and 
experience, their personality, values and life experience. Most healthcare professionals indicated to 
be able to switch between roles, although others inclined more towards one of the roles. In this 





approached towards self-management and self-management support. Therefore, the instructive, 
collaborative and advisory support roles will all be useful under certain circumstances. 
 
Part II: ACP in patients with an ICD 
Chapter 5 describes the results of an integrative review which provided an overview of all studies 
reporting on ICD shock incidence and the impact of these shocks in the last phase of life in the period 
of 1991 until 2015. Five databases were systematically searched and 15 out of 4246 identified articles 
were included in the analysis. Two studies from 1996 and 1998 reported on patients who died due to 
non-sudden causes. They reported that 24% and 33% of patients experienced shocks in the last 24 
hours of life, and 7% and 14% in the last hour of life. Seven studies, published between 1991 and 1999, 
reported on patients who died due to sudden causes. These studies reported that 41% to 68% of 
patients experienced shocks in the last 24 hours of life and 22% to 66% in the last hour of life. In the 
6 studies published between 2004-2015 that did not make a distinction between patients dying non-
suddenly or suddenly, it was reported that 17% to 32% of patients experienced shocks in the last 
month of life, 3% to 32% in the last 24 hours, and 8% to 31% in the last hour of life. Three studies, 
published between 2004 and 2011, examined the impact of these shocks on the patients, their 
relatives, and attending healthcare professionals. They reported that shocks were considered painful 
and distressing to patients, and were distressing for relatives and attending healthcare professionals. 
These findings emphasise that it is important that healthcare professionals discuss ICD deactivation in 
a timely manner with the patient and his or her relatives. This can contribute to timely deactivation of 
the ICD shock function, and therefore can minimise possible suffering due to shocks, thereby 
promoting a calm and peaceful death. 
 
Chapter 6 includes the results of a retrospective case study in which 380 medical records of deceased 
patients with an ICD were examined. Trends in time (2007-2016) in how and when decisions were 
made about ICD deactivation were described and factors related to this decision were outlined. In 
addition, care and ICD shock incidence in the last month of life were described. In the medical records, 
we found that the occurrence of ICD deactivation discussions increased over the years. Six percent of 
the patients who died between 2007 and 2009 had a discussion about ICD deactivation reported in 
their medical record, compared to 35% of patients who died between 2013 and 2016. Also, the 
occurrence of actual ICD deactivation increased in this time period, from 16% to 42%. Factors related 
to deactivating the ICD were: having had an ICD deactivation discussion, a valid do-not-resuscitate 
order or do-not-intubate order, and the prior involvement of a palliative care team. For patients who 





these patients. This chapter concluded that, although discussions about ICD deactivation and actual 
deactivation have increased since 2007, ICDs remain active in the majority of patients at the end of 
life, some of whom experience shocks. 
 
Chapter 7 elaborates on the results of a focus group study in which 41 patients with ICDs participated. 
In the focus groups, insight was gained in the experiences of these patients with ACP conversations 
about ICD deactivation. Although not all patients knew that deactivating the ICD was an option, most 
patients could imagine deciding to have their ICD deactivated one day. Different reasons were given 
for this, often encompassing an assessment of the balance between quality and length of life. Some 
patients indicated to have a need for having ACP conversations with their healthcare professional, but 
few had had these. Some patients indicated that healthcare professionals were knowledgeable on 
medical-technological domains, but that there was not always an opportunity to discuss issues with a 
strong emotional component, such as the end of life. Some patients said they did not have a need for 
having ACP conversations. These patients said they were solely focussed on living in the ‘here and 
now’. Patients were often hesitant to record their preferences about ICD deactivation in advance care 
directives, since they were unsure about whether their current preferences would reflect their future 
preferences. This chapter concluded that ACP conversations about ICD deactivation should occur 
more frequently, but should be tailored to the illness stage of the patient and the readiness to discuss 
this topic. 
 
Chapter 8 describes the results of a mixed-methods study. A total of 170 relatives of deceased ICD 
patients completed a survey, of which 23 relatives also participated in focus groups. We examined the 
experiences of these relatives with ACP discussions about ICD deactivation, and with treatment and 
care in the last phase of life of the patient. We found that, according to the relatives, 38% of the 
patients had had an ACP conversation with a healthcare professional about ICD deactivation, and that 
24% of the patients had experienced one or more shocks in the last month of life, which were 
distressing for 74% of patients and 73% of relatives. The ICD was deactivated in 55% of the patients. 
Relatives reported numerous barriers towards having ACP conversations with healthcare 
professionals. These included, amongst others, patients’ lack of willingness to talk about ICD 
deactivation, having a bad relationship with the healthcare professional and a perceived lack of time 
from the professional. Relatives had both positive and negative experiences with the treatment and 
care in the last phase of life, and 42% to 61% of relatives reported to be satisfied with different aspects 
of this care. Quality of death was rated relatively low by relatives, but was significantly higher for 





patients who died with an active ICD (quality of death 5.67). This chapter concluded that ACP 
conversations about ICD deactivation are rare, and suggested that healthcare professionals should be 
educated about having these conversations with their patients. 
 
Chapter 9 presents a viewpoint on the experienced barriers of healthcare professionals towards 
having ACP conversations about ICD deactivation with their patients. We could synthesize a total of 
31 barriers from interviews with 26 healthcare professionals involved in the care for ICD patients at 
the end of life. These were related to clinical practice, such as having a lack of time or knowledge, and 
having difficulties finding the right moment to discuss the topic; the patient, such as experiencing 
reluctance in the patient to discuss the topic, a lack of knowledge in the patient about the functioning 
of the ICD, and an overestimation of the life-saving capacity of the ICD; and society, such as a 
predominant focus of healthcare and society on treating and curing illness. In this chapter, 
development and implementation of a program aimed at educating healthcare professionals involved 
in the care for patients with an ICD at the end of their lives was suggested. It is advocated that ACP 
and discussions about care at the end of life should become an integral part of cardiologic care. Only 
then the number of patients experiencing inappropriate and painful shocks at the end of their lives 
can be reduced. 
 
In chapter 10, I elaborate on the results of the studies included in this thesis in a general discussion. 
In this chapter, the main findings of this thesis are summarised and discussed, methodological 
considerations are outlined, and recommendations for clinical practice and future research are given. 
I conclude that living with a progressive, life-threatening illness is hard work. Although some patients 
seem to be able to effectively deal with the many consequences of their illness, for others this can be 
a burden, and these patients are overwhelmed by the work of having a progressive illness, while 
mostly they just want to live life as normally as possible. Further, patients show a variety in the need 
and willingness to engage in ACP. Some patients specifically thought about and discussed their 
preferences for future medical treatment and care, while others were focussed on living in the ‘here 
and now’. Self-management is very much individually determined, and so is the need for self-
management support and having ACP conversations. Patients can benefit by being educated about 
general self-management skills, early in their illness trajectory. Subsequently, I advocate an individual 
approach to self-management support. In order to do so, it is important to have frequent ‘self-
management check-ups’, performed by a central, coordinating caregiver. This caregiver, presumably 
a nurse, discusses with the patient his or her self-management, expectations, responsibilities, needs 





check-ups, ACP should also be an important topic. In order to have these in-depth discussions with 
the patient it is important to have a strong healthcare professional – patient relationship, based on 
trust. In order for healthcare professionals to be skilled in supporting the patients’ self-management 







Hoofdstuk 1 bevat een algemene introductie op dit proefschrift over zelfmanagement en advance 
care planning (ACP) van patiënten met progressieve, levensbedreigende ziekten. Het beschrijft de 
verschuiving van gezondheidszorg gebaseerd op het biomedische model, waarbij de zorgverlener 
zelfstandig beslissingen nam over behandelingen, vaak zonder de patiënt te raadplegen, naar 
gezondheidszorg op basis van het biopsychosociale model, waarbij meer nadruk wordt gelegd op 
individuele keuze en autonomie van de patiënt, en waarin gedeelde besluitvorming een belangrijke 
rol speelt. In het biopsychosociale model wordt een grote rol en verantwoordelijkheid bij de patiënt 
gelegd, terwijl tegelijkertijd de gezondheidszorg versnippert en steeds meer gespecialiseerd en 
complex wordt. Het is niet bekend in hoeverre patiënten een actieve rol in hun zorg willen en kunnen 
spelen. Zelfmanagement, in deze context gedefinieerd als "de strategieën die personen gebruiken om 
te kunnen omgaan met de fysieke, psychosociale en existentiële gevolgen van het leven met een 
progressieve, levensbedreigende ziekte en de behandeling daarvan" krijgt steeds meer aandacht in 
onderzoek en in de klinische praktijk, maar is weinig onderzocht bij patiënten met een gevorderde 
ziekte. Daarnaast is er weinig bekend over ACP bij patiënten met andere gevorderde ziekten dan 
kanker. Het doel van dit proefschrift was om inzicht te krijgen in zelfmanagement en ACP van 
patiënten met een gevorderde ziekte. Zelfmanagement werd onderzocht in een populatie van 
patiënten met gevorderde kanker en ACP werd onderzocht in een populatie van patiënten met een 
implanteerbare cardioverter defibrillator (ICD). 
 
Deel I: zelfmanagement van patiënten met gevorderde kanker 
Hoofdstuk 2 presenteert de resultaten van een systematisch literatuuronderzoek naar 
zelfmanagement van patiënten met gevorderde kanker. Zeven databases werden systematisch 
doorzocht en 31 van de 1742 geïdentificeerde artikelen werden geïncludeerd. Deze studies, waarvan 
8 met een kwantitatieve en 23 met een kwalitatieve onderzoeksopzet, rapporteerden over een 
verscheidenheid aan zelfmanagementgedrag in zeven domeinen: geneeskunde en farmacologie, 
levensstijl, geestelijke gezondheid, sociale ondersteuning, kennis en informatie, navigatie en 
coördinatie van zorg en medische besluitvorming. We vonden dat zelfmanagement van patiënten 
individueel en soms ambivalent was. Zelfmanagement werd beïnvloed door leeftijd, mentale 
toestand, fysiek functioneren, opleiding en ‘zelf-effectiviteit’, ofwel het vertrouwen dat mensen 
hebben in hun eigen bekwaamheid om met succes hun situatie te beïnvloeden. Oudere patiënten, 
patiënten met depressieve symptomen en mensen met een lager niveau van fysiek functioneren, 
opleiding en zelf-effectiviteit worstelden soms met zelfmanagement. Uit drie onderzoeken bleek dat 





vaardigheden, kennis en een goede relatie tussen zorgverlener en patiënt. Dit hoofdstuk concludeert 
dat zelfmanagement persoonlijk en veelzijdig is. Ondersteuning van zelfmanagement heeft baat bij 
een geïndividualiseerde aanpak, ingebed in een goede samenwerking tussen patiënt, familieleden en 
zorgverleners. 
 
Hoofdstuk 3 bevat de resultaten van een kwalitatief onderzoek waarin 33 patiënten met gevorderde 
kanker werden geïnterviewd. Patiënten gaven aan dat hun diagnose een grote impact had op 
verschillende domeinen van het leven, namelijk fysiek, psychologisch, sociaal, existentieel, medisch 
en het dagelijks leven. Patiënten lieten verschillende vormen van zelfmanagement zien om te kunnen 
omgaan met deze gevolgen. Dit zelfmanagement werd onderverdeeld in zes categorieën: gedrag 
gericht op gezondheidsbevordering, zoals lichamelijk actief blijven en een gezond dieet aanhouden; 
gedrag om psychologische gevolgen te beheersen, zoals het nuanceren van gedachten of het 
opschrijven van gedachten in een notitieboek; gedrag gericht op het zoeken naar en verlenen van 
sociale steun; gedrag gericht op het samenwerken met professionele zorgverleners; gedrag gericht op 
het verkrijgen van kennis en informatie; en gedrag gerelateerd aan plannen, zoals het plannen van het 
dagelijks leven en het volgen van medicatieschema's. Patiënten gaven aan dat ze het belangrijk vinden 
om een zo normaal mogelijk leven te leiden. Verschillende factoren leken zelfmanagement van 
patiënten te beïnvloeden, zoals hun persoonlijkheid, hun levensgeschiedenis, het moment in het 
ziektetraject en de betrokkenheid van hun sociale omgeving. De meeste patiënten wisten niet altijd 
waarom ze op een bepaalde manier met de gevolgen van hun ziekte omgingen. Ze gaven vaak aan dat 
ze al op een bepaalde manier omgingen met uitdagingen in het leven. Dit suggereert dat patiënten 
proberen te putten uit hun reeds bestaande zelfmanagementgedrag om te kunnen omgaan met het 
leven met gevorderde kanker. 
 
Hoofdstuk 4 rapporteert de resultaten van een kwalitatief onderzoek waarin 27 zorgverleners 
betrokken bij de zorg voor patiënten met gevorderde kanker werden geïnterviewd. Het doel was om 
de ervaringen en opvattingen van zorgverleners met betrekking tot zelfmanagement van patiënten 
met gevorderde kanker te onderzoeken, en een beschrijving te geven van hun rol in 
zelfmanagementondersteuning. Over het algemeen waren zorgverleners optimistisch over 
zelfmanagement van hun patiënten, hoewel sommigen bezorgd waren over de patiënten die minder 
in staat leken te zijn tot zelfmanagement. Zorgverleners namen verschillende rollen aan bij het 
ondersteunen van zelfmanagement. Dit waren: de instructieve rol, waarin de zorgverlener een 
leidende rol op zich neemt en zelfmanagement van de patiënt aanstuurt op basis van zijn eigen 





en patiënten zichtbaar is; en de adviserende rol waarin de patiënt de leiding heeft en de zorgverlener 
een meer dienende rol op zich neemt. Zorgverleners schreven hun rol toe aan patiëntkenmerken, 
maar ook aan hun eigen werkomstandigheden en ervaring, hun persoonlijkheid, waarden en 
levenservaring. De meeste zorgverleners gaven aan te kunnen schakelen tussen deze verschillende 
rollen, alhoewel sommigen meer neigden naar een van de rollen. In dit hoofdstuk concluderen we dat 
zorgverleners, net zoals patiënten, verschillen in hun opvattingen en benadering wat betreft 
zelfmanagement en zelfmanagementondersteuning. Zowel de instructieve, samenwerkende en 
adviserende rol zijn allen bruikbaar onder verschillende omstandigheden. 
 
Deel II: ACP bij patiënten met een ICD 
Hoofdstuk 5 beschrijft de resultaten van een literatuuronderzoek, welke een overzicht geeft van alle 
onderzoeken die rapporteren over de incidentie van ICD shocks en de impact van deze shocks op de 
laatste fase van het leven. Vijf databases werden systematisch doorzocht en 15 van de 4246 
geïdentificeerde artikelen, gepubliceerd in de periode van 1991 tot 2015, werden geïncludeerd. Twee 
studies uit 1996 en 1998 rapporteerden over patiënten die overleden aan niet-plotselinge oorzaken. 
Deze studies rapporteerden dat 24% en 33% van de patiënten shocks ervaarden in de laatste 24 uur 
van het leven, en 7% en 14% van de patiënten in het laatste uur van het leven. Zeven studies, 
gepubliceerd tussen 1991 en 1999, rapporteerden over patiënten die overleden aan plotselinge 
oorzaken. Deze studies rapporteerden dat 41% tot 68% van de patiënten shocks ervaarden in de 
laatste 24 uur van het leven en 22% tot 66% van de patiënten in het laatste uur van het leven. In de 6 
studies gepubliceerd tussen 2004 en 2015 die geen onderscheid maakten tussen doodsoorzaak, werd 
gerapporteerd dat 17% tot 32% van de patiënten shocks ervaarden in de laatste maand van het leven, 
3% tot 32% in de laatste 24 uur en 8% tot 31% van de patiënten in het laatste uur van het leven. Drie 
studies, gepubliceerd tussen 2004 en 2011, onderzochten de impact van ICD shocks op patiënten, hun 
naasten en zorgverleners. Ze rapporteerden dat shocks pijnlijk en stressvol waren voor patiënten en 
stressvol voor naasten en zorgverleners. De bevindingen in dit hoofdstuk benadrukken dat het 
belangrijk is dat zorgverleners ICD deactivatie vroegtijdig met de patiënt en hun naasten bespreken. 
Dit kan bijdragen aan het tijdig deactiveren van de shockfunctie van de ICD, waardoor shocks kunnen 
worden voorkomen. Dit bevordert een rustig en comfortabel sterven. 
 
Hoofdstuk 6 bevat de resultaten van een retrospectief dossieronderzoek waarin 380 medische 
dossiers van overleden patiënten met een ICD zijn onderzocht. In dit hoofdstuk wordt beschreven hoe 
de besluitvorming omtrent het deactiveren van de ICD al dan niet is veranderd in de periode van 2007 





en worden de zorg en incidentie van ICD shocks in de laatste maand van het leven beschreven. Uit het 
dossieronderzoek bleek dat het aantal gesprekken over ICD deactivatie in de loop der jaren is 
toegenomen. Bij de patiënten die overleden tussen 2007 en 2009 werd in 6% van de medische dossiers 
een aantekening over een gesprek over ICD deactivatie gevonden, vergeleken met 35% van de 
dossiers van mensen die overleden tussen 2013 en 2016. Daarnaast zagen we dat het aantal ICD 
deactivaties toenam, van 16% in de periode van 2007 tot 2009, tot 42% in de periode van 2013 tot 
2016. Verschillende factoren waren geassocieerd met het deactiveren van de ICD, zoals een gesprek 
over ICD deactivatie, een niet-reanimeren of niet-intuberen beleid en de betrokkenheid van een 
consultatieteam palliatieve zorg. Van de patiënten die overleden met een actieve ICD, werd bij 7% een 
aantekening in het dossier gevonden dat deze patiënt een shock heeft gekregen in de laatste maand 
van het leven. Dit hoofdstuk concludeert dat, hoewel gesprekken over ICD deactivatie en het 
daadwerkelijke aantal ICD deactivaties sinds 2007 zijn toegenomen, de meerderheid van de patiënten 
overlijdt met een actieve ICD, van wie sommigen een of meerdere shocks krijgen in de laatste maand 
voor overlijden. 
 
Hoofdstuk 7 rapporteert de resultaten van een focusgroep onderzoek waaraan 41 patiënten met een 
ICD deelnamen. In de focusgroepen werd inzicht verkregen in de ervaringen van deze patiënten met 
ACP gesprekken over ICD deactivatie. Hoewel niet alle patiënten wisten dat het deactiveren van de 
ICD een optie was, konden de meeste patiënten zich voorstellen dat ze op een dag zouden besluiten 
hun ICD te deactiveren. Hiervoor werden verschillende redenen gegeven, waarbij vaak een afweging 
werd gemaakt tussen kwaliteit van leven en levensduur. Sommige patiënten gaven aan behoefte te 
hebben aan ACP gesprekken met hun zorgverlener, maar slechts weinigen hadden deze gehad. 
Sommige patiënten gaven aan dat zorgverleners veel kennis hadden op medisch-technologische 
gebied, maar dat er niet altijd gelegenheid was om zaken te bespreken met een sterk emotioneel 
component, zoals het levenseinde. Sommige patiënten vertelden dat ze geen behoefte hadden aan 
ACP gesprekken. Deze patiënten zeiden dat ze uitsluitend gericht waren op het leven in het ‘hier en 
nu’. Patiënten aarzelden vaak om hun voorkeuren met betrekking tot het deactiveren van de ICD vast 
te leggen, omdat ze niet zeker wisten of hun huidige voorkeuren hun toekomstige voorkeuren zouden 
weerspiegelen. Dit hoofdstuk concludeert dat ACP gesprekken over het deactiveren van ICDs vaker 
zouden moeten plaatsvinden, maar dat deze wel moeten worden afgestemd op het ziektestadium van 
de patiënt en de bereidheid van de patiënt om dit onderwerp te bespreken. 
 
Hoofdstuk 8 beschrijft de resultaten van een onderzoek met een ‘mixed-methods’ design. 





vragenlijst in, waarvan er 23 ook deelnamen aan focusgroepen. In dit onderzoek werden de ervaringen 
van de naasten met ACP gesprekken over ICD deactivatie en met de behandeling en zorg in de laatste 
levensfase van de patiënt onderzocht.  Volgens de naasten had 38% van de patiënten een ACP gesprek 
gevoerd met een zorgverlener over het deactiveren van de ICD, en 24% van de patiënten had een of 
meerdere shocks van hun ICD hadden gekregen in de laatste maand van het leven. Deze shocks waren 
stressvol voor 74% van de patiënten en 73% van de naasten. Bij 55% van de patiënten was de ICD 
voorafgaand aan het overlijden gedeactiveerd. De naasten beschreven verschillende barrières voor 
het hebben van ACP gesprekken, waaronder een gebrek aan bereidheid van patiënten om te praten 
over het uitschakelen van de ICD, een slechte relatie met de zorgverlener en gebrek aan tijd van de 
zorgverlener. Naasten hadden zowel positieve als negatieve ervaringen met de behandeling en zorg 
in de laatste levensfase, en 42% tot 61% van de naasten gaf aan tevreden te zijn met verschillende 
aspecten van deze zorg. De kwaliteit van sterven werd relatief laag beoordeeld, maar was significant 
hoger voor patiënten die overleden met een gedeactiveerde ICD (kwaliteit van overlijden 6,7 op een 
10-puntsschaal) vergeleken met patiënten die overleden met een actieve ICD (kwaliteit van overlijden 
5,7). Dit hoofdstuk concludeert dat ACP gesprekken over het deactiveren van ICDs weinig voorkomen, 
en raadt aan dat zorgverleners geschoold moeten worden in het voeren van ACP gesprekken met hun 
patiënten. 
 
Hoofdstuk 9 presenteert de resultaten van een onderzoek naar de barrières die zorgverleners ervaren 
bij het voeren van ACP gesprekken over ICD deactivatie met hun patiënten. In interviews met 26 
zorgverleners die betrokken waren bij de zorg voor patiënten met een ICD in de laatste fase van het 
leven identificeerden we in totaal 31 barrières voor het voeren van ACP gesprekken over ICD 
deactivatie. Deze barrières werden onderverdeeld in drie categorieën: barrières gerelateerd aan de 
klinische praktijk, zoals een gebrek aan tijd of kennis en moeite hebben met het vinden van het juiste 
moment om het onderwerp te bespreken; barrières gerelateerd aan de patiënt, zoals veronderstelde 
onwil van de patiënt om het onderwerp te bespreken, een gebrek aan kennis bij de patiënt over het 
functioneren van de ICD, en een overschatting door de patiënt van de levensreddende mogelijkheid 
van de ICD; en barrières gerelateerd aan de samenleving, zoals de focus van de gezondheidszorg en 
samenleving op het behandelen en genezen van ziekten. In dit hoofdstuk wordt voorgesteld om een 
programma te ontwikkelen en te implementeren dat gericht is op het scholen van zorgverleners die 
betrokken zijn bij de zorg voor patiënten met een ICD in de laatste levensfase. Daarnaast wordt 
voorgesteld dat ACP en gesprekken over zorg aan het levenseinde een integraal onderdeel van 
cardiologische zorg zouden moeten worden. Alleen dan kan het aantal patiënten dat ongepaste en 






Hoofdstuk 10 beschrijft de algemene discussie van dit proefschrift. Dit hoofdstuk bevat een 
samenvatting en bespreking van de belangrijkste bevindingen van dit proefschrift en de gebruikte 
methodologie, en bevat aanbevelingen voor zowel de klinische praktijk als voor toekomstig 
onderzoek. Ik concludeer dat het leven met een progressieve, levensbedreigende ziekte hard werken 
is voor de patiënt. Hoewel sommige patiënten goed om lijken te gaan met de gevolgen van hun ziekte, 
ervaren sommigen hun ziekte als een grote last en worden ze overweldigd door het werk wat hierbij 
komt kijken, terwijl zij vooral een zo normaal mogelijk leven proberen te leiden. Daarnaast verschilden 
patiënten in hun behoefte en bereidheid om deel te nemen aan ACP. Sommige patiënten dachten 
specifiek na over hun voorkeuren voor toekomstige medische behandeling en zorg en bespraken deze, 
terwijl anderen gericht waren op het leven in het ‘hier en nu’. Zelfmanagement van de patiënt is 
individueel bepaald, net zoals de behoefte van de patiënt aan zelfmanagementondersteuning en het 
voeren van ACP gesprekken. Patiënten kunnen er baat bij hebben om al vroeg in hun ziekteproces te 
worden voorgelicht over algemene vaardigheden op het gebied van zelfmanagement. Ik pleit voor een 
individuele benadering van zelfmanagementondersteuning. Hiervoor is het belangrijk dat de patiënt 
regelmatig gesprekken heeft met een centrale, coördinerende zorgverlener. Deze zorgverlener, 
bijvoorbeeld een verpleegkundige, evalueert met de patiënt zijn of haar zelfmanagement, 
verwachtingen, verantwoordelijkheden, behoeften en voorkeuren, en kan de patiënt indien nodig 
doorverwijzen naar andere zorgverleners. Tijdens deze gesprekken moet ACP ook een belangrijk 
onderwerp zijn. Een sterke relatie tussen de zorgverlener en de patiënt, gebaseerd op vertrouwen, is 
een belangrijke voorwaarde om deze diepgaande gesprekken te kunnen voeren. Om ervoor te zorgen 
dat zorgverleners bekwaam zijn in het ondersteunen van zelfmanagement van de patiënten en in het 
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